Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - AMERICAN PACIFIC CORP | p16845exv31w1.htm |
EX-32.1 - EX-32.1 - AMERICAN PACIFIC CORP | p16845exv32w1.htm |
EX-31.2 - EX-31.2 - AMERICAN PACIFIC CORP | p16845exv31w2.htm |
EX-32.2 - EX-32.2 - AMERICAN PACIFIC CORP | p16845exv32w2.htm |
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended December 31, 2009
or
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-08137
AMERICAN PACIFIC CORPORATION
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
59-6490478 (I.R.S. Employer Identification No.) |
3883 Howard Hughes Parkway, Suite 700
Las Vegas, Nevada 89169
(Address of principal executive offices) (Zip Code)
Las Vegas, Nevada 89169
(Address of principal executive offices) (Zip Code)
(702) 735-2200
(Registrants telephone number, including area code)
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. YES þ
No o
Indicate by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). Yes
o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act.
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company þ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act). Yes o No þ
The number of shares of the registrants common stock outstanding as of February 1, 2010
was 7,540,591.
AMERICAN PACIFIC CORPORATION
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
- i -
Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
AMERICAN
PACIFIC CORPORATION
Condensed Consolidated Statements of Operations
(Unaudited, Dollars in Thousands, Except per Share Amounts)
(Unaudited, Dollars in Thousands, Except per Share Amounts)
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Revenues |
$ | 34,064 | $ | 45,629 | ||||
Cost of Revenues |
21,618 | 30,895 | ||||||
Gross Profit |
12,446 | 14,734 | ||||||
Operating Expenses |
12,307 | 11,309 | ||||||
Operating Income |
139 | 3,425 | ||||||
Interest and Other Income (Expense), Net |
(8 | ) | 61 | |||||
Interest Expense |
2,691 | 2,694 | ||||||
Income (Loss) before Income Tax |
(2,560 | ) | 792 | |||||
Income Tax Expense (Benefit) |
(1,120 | ) | 335 | |||||
Net Income (Loss) |
$ | (1,440 | ) | $ | 457 | |||
Earnings (Loss) per Share: |
||||||||
Basic |
$ | (0.19 | ) | $ | 0.06 | |||
Diluted |
$ | (0.19 | ) | $ | 0.06 | |||
Weighted Average Shares Outstanding: |
||||||||
Basic |
7,487,000 | 7,480,000 | ||||||
Diluted |
7,487,000 | 7,573,000 |
See accompanying notes to condensed consolidated financial statements
- 1 -
Table of Contents
AMERICAN
PACIFIC CORPORATION
Condensed Consolidated Balance Sheets
(Unaudited, Dollars in Thousands, Except per Share Amounts)
(Unaudited, Dollars in Thousands, Except per Share Amounts)
December 31, | September 30, | |||||||
2009 | 2009 | |||||||
ASSETS |
||||||||
Current Assets: |
||||||||
Cash and Cash Equivalents |
$ | 38,619 | $ | 21,681 | ||||
Accounts Receivable, Net |
23,889 | 44,028 | ||||||
Inventories |
47,783 | 36,356 | ||||||
Prepaid Expenses and Other Assets |
2,353 | 1,811 | ||||||
Income Taxes Receivable |
2,439 | 2,148 | ||||||
Deferred Income Taxes |
6,317 | 6,317 | ||||||
Total Current Assets |
121,400 | 112,341 | ||||||
Property, Plant and Equipment, Net |
112,634 | 114,645 | ||||||
Intangible Assets, Net |
3,005 | 3,553 | ||||||
Goodwill |
3,088 | 3,144 | ||||||
Deferred Income Taxes |
21,122 | 21,121 | ||||||
Other Assets |
10,150 | 10,037 | ||||||
TOTAL ASSETS |
$ | 271,399 | $ | 264,841 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current Liabilities: |
||||||||
Accounts Payable |
$ | 8,217 | $ | 7,444 | ||||
Accrued Liabilities |
7,084 | 5,295 | ||||||
Accrued Interest |
4,125 | 1,650 | ||||||
Employee Related Liabilities |
5,282 | 6,930 | ||||||
Income Taxes Payable |
201 | 189 | ||||||
Deferred Revenues and Customer Deposits |
11,101 | 6,911 | ||||||
Current Portion of Environmental Remediation Reserves |
2,110 | 2,522 | ||||||
Current Portion of Long-Term Debt |
121 | 151 | ||||||
Total Current Liabilities |
38,241 | 31,092 | ||||||
Long-Term Debt |
110,131 | 110,097 | ||||||
Environmental Remediation Reserves |
23,898 | 24,168 | ||||||
Pension Obligations |
28,573 | 27,720 | ||||||
Other Long-Term Liabilities |
628 | 667 | ||||||
Total Liabilities |
201,471 | 193,744 | ||||||
Commitments and Contingencies |
||||||||
Shareholders Equity |
||||||||
Preferred Stock $1.00 par value; 3,000,000 authorized; none outstanding |
| | ||||||
Common Stock
$0.10 par value; 20,000,000 shares authorized, 7,540,591 and 7,504,591 issued |
754 | 750 | ||||||
Capital in Excess of Par Value |
72,664 | 72,322 | ||||||
Retained Earnings |
8,557 | 9,997 | ||||||
Accumulated Other Comprehensive Loss |
(12,047 | ) | (11,972 | ) | ||||
Total Shareholders Equity |
69,928 | 71,097 | ||||||
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY |
$271,399 | $ | 264,841 | |||||
See accompanying notes to condensed consolidated financial statements
- 2 -
Table of Contents
AMERICAN
PACIFIC CORPORATION
Condensed Consolidated Statements of Cash Flows
(Unaudited, Dollars in Thousands)
(Unaudited, Dollars in Thousands)
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Cash Flows from Operating Activities: |
||||||||
Net Income (Loss) |
$ | (1,440 | ) | $ | 457 | |||
Adjustments to Reconcile Net Income (Loss)to Net Cash Provided by Operating Activities: |
||||||||
Depreciation and amortization |
4,053 | 3,969 | ||||||
Non-cash interest expense |
159 | 159 | ||||||
Share-based compensation |
346 | 132 | ||||||
Excess tax benefit from stock option exercises |
| (3 | ) | |||||
Deferred income taxes |
(44 | ) | (58 | ) | ||||
Loss on sale of assets |
5 | 53 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable, net |
20,141 | 6,661 | ||||||
Inventories |
(11,323 | ) | (3,052 | ) | ||||
Prepaid expenses and other current assets |
(540 | ) | (12 | ) | ||||
Accounts payable |
296 | (2,627 | ) | |||||
Income taxes |
(279 | ) | 325 | |||||
Accrued liabilities |
1,791 | 631 | ||||||
Accrued interest |
2,475 | 2,509 | ||||||
Employee related liabilities |
(1,643 | ) | (2,739 | ) | ||||
Deferred revenues and customer deposits |
4,208 | 415 | ||||||
Environmental remediation reserves |
(682 | ) | (367 | ) | ||||
Pension obligations, net |
853 | 576 | ||||||
Other |
(269 | ) | (79 | ) | ||||
Net Cash Provided by Operating Activities |
18,107 | 6,950 | ||||||
Cash Flows from Investing Activities: |
||||||||
Capital expenditures |
(1,099 | ) | (1,809 | ) | ||||
Acquisition of business, net of cash acquired |
| (6,653 | ) | |||||
Net Cash Used by Investing Activities |
(1,099 | ) | (8,462 | ) | ||||
Cash Flows from Financing Activities: |
||||||||
Payments of long-term debt |
(59 | ) | (108 | ) | ||||
Issuances of common stock, net |
| 32 | ||||||
Excess tax benefit from stock option exercises |
| 3 | ||||||
Net Cash Used by Financing Activities |
(59 | ) | (73 | ) | ||||
Effect of Changes in Currency Exchnage Rates on Cash |
(11 | ) | | |||||
Net Change in Cash and Cash Equivalents |
16,938 | (1,585 | ) | |||||
Cash and Cash Equivalents, Beginning of Period |
21,681 | 26,893 | ||||||
Cash and Cash Equivalents, End of Period |
$ | 38,619 | $ | 25,308 | ||||
Cash Paid (Received) For: |
||||||||
Interest |
$ | 57 | $ | 55 | ||||
Income taxes |
(801 | ) | 6 | |||||
Non-Cash Investing and Financing Transactions: |
||||||||
Additions to Property, Plant and Equipment not yet paid |
778 | 897 | ||||||
Capital Leases Originated |
65 | |
See accompanying notes to condensed consolidated financial statements
- 3 -
Table of Contents
AMERICAN PACIFIC CORPORATION
Notes to Condensed Consolidated Financial Statements
(Unaudited, Dollars in Thousands, Except per Share Amounts)
(Unaudited, Dollars in Thousands, Except per Share Amounts)
1. | INTERIM BASIS OF PRESENTATION AND ACCOUNTING POLICIES |
Interim Basis of Presentation. The accompanying condensed consolidated financial statements of
American Pacific Corporation and its subsidiaries (collectively, the Company, we, us, or
our) are unaudited, but in the opinion of management, include all adjustments, which are of a
normal recurring nature, necessary to a fair statement of the results for the interim periods
presented. These statements should be read in conjunction with our consolidated financial
statements and notes thereto included in our Annual Report on Form 10-K for the year ended
September 30, 2009. We have evaluated subsequent events through February 12, 2010, the date
these condensed consolidated financial statements were issued. The operating results and cash
flows for the three-month period ended December 31, 2009 are not necessarily indicative of the
results that will be achieved for the full fiscal year or for future periods.
Accounting Policies. A description of our significant accounting policies is included in Note 1
to our consolidated financial statements included in our Annual Report on Form 10-K for the year
ended September 30, 2009.
Principles of Consolidation. Our consolidated financial statements include the accounts of
American Pacific Corporation and our wholly-owned subsidiaries. All intercompany accounts have
been eliminated.
Effective October 1, 2008, we acquired Marotta Holdings Limited (subsequently renamed Ampac ISP
Holdings Limited) and its wholly-owned subsidiaries (collectively AMPAC ISP Holdings) for a
cash purchase price, including direct expenses and net of cash acquired, of $6,725. AMPAC ISP
Holdings was included in our consolidated financial statements beginning on October 1, 2008 and
is a component of our Aerospace Equipment segment.
Fair Value Disclosure of Financial Instruments. We estimate the fair values of cash and cash
equivalents, accounts receivable, accounts payable and accrued liabilities approximate their carrying
values due to their short-term nature. We estimate the fair value of our fixed-rate
long-term debt to be approximately $105,600 based on and accrued liabilities approximate their
carrying values due to their short-term nature. We estimate the trade date closest to December 31,
2009, which was January 14, 2010.
Depreciation and Amortization Expense. Depreciation expense of $3,361 and $3,325 was classified
as cost of revenues in our consolidated statements of operations for the three-month periods
ended December 31, 2009 and 2008, respectively. Depreciation expense of $148 and $136 was
classified as operating expenses in our consolidated statements of operations for the
three-month periods ended December 31, 2009 and 2008, respectively.
Amortization expense of $544 and $508 was classified as operating expenses in our consolidated
statements of operations for the three-month periods ended December 31, 2009 and 2008,
respectively.
Bill and Hold Transactions. Some of our perchlorate and fine chemicals products customers have
requested that we store materials purchased from us in our facilities (Bill and Hold
arrangements). The sales value of inventory, subject to Bill and Hold arrangements, at our
facilities was $21,786 and $25,882 as of December 31, 2009 and September 30, 2009, respectively.
Recently Issued or Adopted Accounting Standards. In September 2006, the Financial Accounting
Standards Board (the FASB) issued a new standard which defines fair value, establishes a
framework for measuring fair value in generally accepted accounting principles in the United
States of
- 4 -
Table of Contents
1. | INTERIM BASIS OF PRESENTATION AND ACCOUNTING POLICIES (continued) |
America, and expands disclosures about fair value measurements. In February 2008, the FASB
deferred this standard for one year as it applied to certain items, including assets and
liabilities initially measured at fair value in a business combination, reporting units and
certain assets and liabilities measured at fair value in connection with goodwill impairment
tests, and long-lived assets measured at fair value for impairment assessments. The standard
applies under other accounting pronouncements that require or permit fair value measurements,
the FASB having previously concluded in those accounting pronouncements that fair value is the
relevant measurement attribute. This standard was effective for us on October 1, 2008; however,
we did not adopt all the provisions of the standard as the FASB delayed the effective date of
its application to non-financial assets and liabilities. The remaining provisions became
effective for us beginning October 1, 2009. The adoption of this standard did not have a
material impact on our results of operations, financial position or cash flows.
In December 2007, the FASB issued a new standard that significantly changed the accounting for
business combinations. Under the standard, an acquiring entity is required to recognize all the
assets acquired and liabilities assumed in a transaction at the acquisition-date fair value with
limited exceptions. The standard also includes a substantial number of new disclosure
requirements. The standard applies to us for business combinations with acquisition dates on or
after October 1, 2009. We expect that the new standard will have an impact on our accounting
for future business combinations, but the effect is dependent upon acquisitions at that time.
In December 2007, the FASB issued a new standard that establishes revised accounting and
reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation
of a subsidiary. Specifically, the standard requires the recognition of a noncontrolling
interest (minority interest) as equity in the consolidated financial statements and separate
from the parents equity. The amount of net income attributable to the noncontrolling interest
will be included in consolidated net income on the face of the income statement. It also
clarifies that changes in a parents ownership interest in a subsidiary that do not result in
deconsolidation are equity transactions if the parent retains its controlling financial
interest. The standard requires that a parent recognize a gain or loss in net income when a
subsidiary is deconsolidated. Such gain or loss will be measured using the fair value of the
noncontrolling equity investment on the deconsolidation date. The standard also includes
expanded disclosure requirements regarding the interests of the parent and its noncontrolling
interest. The standard was effective for us beginning on October 1, 2009. We currently have no
entities or arrangements that were affected by the adoption of this standard.
In April 2008, the FASB issued a new standard which amends the factors that should be considered
in developing renewal or extension assumptions used to determine the useful life of a recognized
intangible asset. The standard for determining the useful life of a recognized intangible
asset shall be applied prospectively to intangible assets acquired after the effective date.
However, the disclosure requirements must be applied prospectively to all intangible assets
recognized in the Companys financial statements as of the effective date. The standard was
effective for us beginning on October 1, 2009. The adoption of this standard did not have a
material impact on our results of operations, financial position or cash flows.
In December 2008, the FASB issued a new standard that provides guidance on an employers
disclosures about plan assets of a defined benefit pension or other postretirement plan. The
objectives of the disclosures include disclosure of investment allocation decisions, major
categories of plan assets, inputs and valuation techniques used to measure the fair value of
plan assets, the effect of certain fair value measurements, and significant concentrations of
risk within plan assets. The expanded disclosure requirements are effective for our fiscal year
ending September 30, 2010. The adoption of this standard is not expected to have a material
impact on our results of operations, financial position or cash flows.
- 5 -
Table of Contents
2. | SHARE-BASED COMPENSATION |
We account for our share-based compensation arrangements under an accounting standard which
requires us to measure the cost of employee services received in exchange for an award of equity
instruments based on the grant date fair value of the award. The fair values of awards are
recognized as additional compensation expense, which is classified as operating expenses,
proportionately over the vesting period of the awards.
Our share-based compensation arrangements are designed to advance the long-term interests of the
Company, including by attracting and retaining employees and directors and aligning their
interests with those of our stockholders. The amount, frequency, and terms of share-based awards
may vary based on competitive practices, our operating results, government regulations and
availability under our equity incentive plans. Depending on the form of the share-based award,
new shares of our common stock may be issued upon grant, option exercise or vesting of the
award. We maintain three share based plans, each as discussed below.
The American Pacific Corporation Amended and Restated 2001 Stock Option Plan (the 2001 Plan)
permits the granting of stock options to employees, officers, directors and consultants. Options
granted under the 2001 Plan generally vested 50% at the grant date and 50% on the one-year
anniversary of the grant date, and expire ten years from the date of grant. As of December 31,
2009, there were no shares available for grant under the 2001 Plan. This plan was approved by
our stockholders.
The American Pacific Corporation 2002 Directors Stock Option Plan, as amended and restated (the
2002 Directors Plan) compensates non-employee directors with stock options granted annually or
upon other discretionary events. Options granted under the 2002 Directors Plan prior to
September 30, 2007 generally vested 50% at the grant date and 50% on the one-year anniversary of
the grant date, and expire ten years from the date of grant. Options granted under the 2002
Directors Plan in November 2007 vested 50% one year from the date of grant and 50% two years
from the date of grant, and expire ten years from the date of grant. As of December 31, 2009,
there were no shares available for grant under the 2002 Directors Plan. This plan was approved
by our stockholders.
The American Pacific Corporation 2008 Stock Incentive Plan (the 2008 Plan) permits the
granting of stock options, restricted stock, restricted stock units and stock appreciation
rights to employees, directors and consultants. A total of 350,000 shares of common stock are
authorized for issuance under the 2008 Plan, provided that no more than 200,000 shares of common
stock may be granted pursuant to awards of restricted stock and restricted stock units.
Generally, awards granted under the 2008 Plan vest in three equal annual installments beginning
on the first anniversary of the grant date, and in the case of option awards, expire ten years
from the date of grant. As of December 31, 2009, there were 12,000 shares available for grant
under the 2008 Plan. This plan was approved by our stockholders.
- 6 -
Table of Contents
2. | SHARE-BASED COMPENSATION (continued) |
A summary of our stock option and restricted stock activity for the three months ended December
31, 2009 is as follows:
Stock Options | Restricted Stock | |||||||||||||||||||||||
Outstanding | Non-Vested | Outstanding and Non-Vested | ||||||||||||||||||||||
Weighted | Weighted | Weighted | ||||||||||||||||||||||
Average | Average | Average | ||||||||||||||||||||||
Exercise | Fair | Fair | ||||||||||||||||||||||
Price | Value | Value | ||||||||||||||||||||||
Shares | Per Share | Shares | Per Share | Shares | Per Share | |||||||||||||||||||
Balance, September 30, 2009 |
540,997 | $ | 8.64 | 161,710 | $ | 5.57 | 22,000 | $ | 11.25 | |||||||||||||||
Granted |
149,000 | 7.21 | 149,000 | 3.65 | 36,000 | 7.15 | ||||||||||||||||||
Vested |
| | (61,065 | ) | 5.62 | (7,336 | ) | 11.25 | ||||||||||||||||
Exercised |
| | | | | | ||||||||||||||||||
Expired / Cancelled |
| | | | | | ||||||||||||||||||
Balance, December 31, 2009 |
689,997 | 8.33 | 249,645 | 4.41 | 50,664 | 8.34 | ||||||||||||||||||
A summary of our exercisable stock options as of December 31, 2009 is as follows:
Number of vested stock options |
440,352 | |||
Weighted-average exercise price per share |
$ | 8.11 | ||
Aggregate intrinsic value |
$ | 277 | ||
Weighted-average remaining contractual term in years |
4.9 |
We determine the fair value of stock option awards at their grant date, using a
Black-Scholes Option-Pricing model applying the assumptions in the following table. We determine
the fair value of restricted stock awards based on the fair market value of our common stock on
the grant date. Actual compensation, if any, ultimately realized by optionees may differ
significantly from the amount estimated using an option valuation model.
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Weighted-average grant date fair value per share of options granted Significant fair value assumptions: |
$ | 3.65 | $ | 5.41 | ||||
Expected term in years |
6.00 | 6.00 | ||||||
Expected volatility |
51.3 | % | 48.7 | % | ||||
Expected dividends |
0.0 | % | 0.0 | % | ||||
Risk-free interest rates |
2.3 | % | 2.7 | % | ||||
Total intrinsic value of options exercised |
$ | | $ | 21 | ||||
Aggregate cash received for option exercises |
$ | | $ | 32 | ||||
Compensation cost (included in operating expenses) |
||||||||
Stock options |
$ | 211 | $ | 108 | ||||
Restricted stock |
135 | 24 | ||||||
Total |
346 | 132 | ||||||
Tax benefit recognized |
73 | 29 | ||||||
Net compensation cost |
$ | 273 | $ | 103 | ||||
As of period end date: |
||||||||
Total compensation cost for non-vested awards
not yet recognized: |
||||||||
Stock options |
$ | 635 | $ | 807 | ||||
Restricted stock |
$ | 187 | $ | 223 | ||||
Weighted-average years to be recognized |
||||||||
Stock options |
1.8 | 1.9 | ||||||
Restricted stock |
1.8 | 1.9 |
- 7 -
Table of Contents
3. | SELECTED BALANCE SHEET DATA |
Inventories. Inventories consist of the following:
December 31, | September 30, | |||||||
2009 | 2009 | |||||||
Finished goods |
$ | 8,646 | $ | 1,951 | ||||
Work-in-process |
24,233 | 22,080 | ||||||
Raw materials and supplies |
10,401 | 9,930 | ||||||
Deferred cost of revenues |
5,079 | 2,395 | ||||||
Under(over) applied manufacturing overhead costs |
(576 | ) | | |||||
Total |
$ | 47,783 | $ | 36,356 | ||||
For our Specialty Chemicals segment, purchase price variances or volume or capacity cost
variances associated with indirect manufacturing costs and that are planned and expected to be
absorbed by goods produced through the end of our fiscal year are deferred at interim reporting
dates as under(over) applied manufacturing overhead costs. The effect of unplanned or
unanticipated purchase price or volume variances are applied to goods produced in the period.
Intangible Assets. Intangible assets consist of the following:
December 31, | September 30, | |||||||
2009 | 2009 | |||||||
Perchlorate customer list |
$ | 38,697 | $ | 38,697 | ||||
Less accumulated amortization |
(38,697 | ) | (38,697 | ) | ||||
| | |||||||
Customer relationships |
9,008 | 9,018 | ||||||
Less accumulated amortization |
(6,527 | ) | (6,182 | ) | ||||
2,481 | 2,836 | |||||||
Backlog |
1,577 | 1,579 | ||||||
Less accumulated amortization |
(1,053 | ) | (862 | ) | ||||
524 | 717 | |||||||
Total |
$ | 3,005 | $ | 3,553 | ||||
The perchlorate customer list is an asset of our Specialty Chemicals segment and was fully
amortized as of February 2008.
Customer relationships are assets of our Fine Chemicals and Aerospace Equipment segments and are
subject to amortization. Amortization expense was $347 and $310 for the three-month periods
ended December 31, 2009 and 2008, respectively.
Backlog is an asset of our Aerospace Equipment segment and is subject to amortization.
Amortization expense was $197 and $200 for the three-month periods ended December 31, 2009 and
2008, respectively.
Goodwill. Goodwill is an asset of our Aerospace Equipment segment and is not expected to be
deductible for tax purposes.
- 8 -
Table of Contents
4. COMPREHENSIVE INCOME (LOSS) AND ACCUMULATED OTHER COMPREHENSIVE LOSS
Comprehensive income (loss) consists of the following:
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Net Income (Loss) |
$ | (1,440 | ) | $ | 457 | |||
Other Comprehensive Income (Loss) - |
||||||||
Foreign currency translation adjustment |
(75 | ) | (537 | ) | ||||
Comprehensive Loss |
$ | (1,515 | ) | $ | (80 | ) | ||
The components of accumulated other comprehensive loss are as follows:
December 31, | September 30, | |||||||
2009 | 2009 | |||||||
Cumulative currency translation adjustment |
$ | (201 | ) | $ | (126 | ) | ||
Unamortized benefit plan costs, net of tax of $7,898 |
(11,846 | ) | (11,846 | ) | ||||
Total |
$ | (12,047 | ) | $ | (11,972 | ) | ||
5. EARNINGS (LOSS) PER SHARE
Shares used to compute earnings (loss) per share are as follows:
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Net income (loss) |
$ | (1,440 | ) | $ | 457 | |||
Basic weighted-average shares |
7,487,000 | 7,480,000 | ||||||
Diluted: |
||||||||
Weighted-average shares, basic |
7,487,000 | 7,480,000 | ||||||
Dilutive effect of stock options |
| 93,000 | ||||||
Weighted-average shares, diluted |
7,487,000 | 7,573,000 | ||||||
Basic earnings (loss) per share |
$ | (0.19 | ) | $ | 0.06 | |||
Diluted earnings (loss) per share |
$ | (0.19 | ) | $ | 0.06 |
As of December 31, 2009 and 2008, we had 689,997 and 202,997 antidilutive options
outstanding, respectively.
6. DEBT
Our outstanding debt balances consist of the following:
December 31, | September 30, | |||||||
2009 | 2009 | |||||||
Senior Notes, 9%, due 2015 |
$ | 110,000 | $ | 110,000 | ||||
Capital Leases, due through 2014 |
252 | 248 | ||||||
Total Debt |
110,252 | 110,248 | ||||||
Less Current Portion |
(121 | ) | (151 | ) | ||||
Total Long-term Debt |
$ | 110,131 | $ | 110,097 | ||||
- 9 -
Table of Contents
6. DEBT (continued)
Senior Notes. In February 2007, we issued and sold $110,000 aggregate principal amount of 9.0%
Senior Notes due February 1, 2015 (collectively, with the exchange notes issued in August 2007
as referenced below, the Senior Notes). Proceeds from the issuance of the Senior Notes were
used to repay our former credit facilities. The Senior Notes accrue interest at an annual rate
of 9.0%, payable semi-annually in February and August. The Senior Notes are guaranteed on a
senior unsecured basis by all of our existing and future material U.S. subsidiaries. The Senior
Notes are:
| ranked equally in right of payment with all of our existing and future senior indebtedness; | ||
| ranked senior in right of payment to all of our existing and future senior subordinated and subordinated indebtedness; | ||
| effectively junior to our existing and future secured debt to the extent of the value of the assets securing such debt; and | ||
| structurally subordinated to all of the existing and future liabilities (including trade payables) of each of our subsidiaries that do not guarantee the Senior Notes. |
The Senior Notes may be redeemed by the Company, in whole or in part, under the following
circumstances:
| at any time prior to February 1, 2011 at a price equal to 100% of the purchase amount of the Senior Notes plus an applicable premium as defined in the related indenture; | ||
| at any time on or after February 1, 2011 at redemption prices beginning at 104.5% of the principal amount to be redeemed and reducing to 100% by February 1, 2013; | ||
| until February 1, 2010, up to 35% of the principal amount of the Senior Notes at a redemption price of 109% of the principal amount thereof, plus accrued and unpaid interest thereon, with the proceeds of certain sales of our equity securities; and | ||
| under certain changes of control, we must offer to purchase the Senior Notes at 101% of their aggregate principal amount, plus accrued interest. |
The Senior Notes were issued pursuant to an indenture which contains certain customary events of
default, including cross default provisions if we default under our existing and future debt
agreements having, individually or in the aggregate, a principal or similar amount outstanding
of at least $10,000, and certain other covenants limiting, subject to exceptions, carve-outs and
qualifications, our ability to:
| incur additional debt; | ||
| pay dividends or make other restricted payments; | ||
| create liens on assets to secure debt; | ||
| incur dividend or other payment restrictions with regard to restricted subsidiaries; | ||
| transfer or sell assets; | ||
| enter into transactions with affiliates; | ||
| enter into sale and leaseback transactions; | ||
| create an unrestricted subsidiary; | ||
| enter into certain business activities; or | ||
| effect a consolidation, merger or sale of all or substantially all of our assets. |
- 10 -
Table of Contents
6. DEBT (continued)
In connection with the closing of the sale of the Senior Notes, we entered into a registration
rights agreement which required us to file a registration statement to offer to exchange the
Senior Notes for notes that have substantially identical terms as the Senior Notes and are
registered under the Securities Act of 1933, as amended. In July 2007, we filed a registration
statement with the SEC with respect to an offer to exchange the Senior Notes as required by the
registration rights agreement, which registration statement was declared effective by the SEC.
In August 2007, we completed the exchange of 100% of the Senior Notes for substantially
identical notes which are registered under the Securities Act of 1933, as amended.
Revolving Credit Facility. In February 2007, we entered into an Amended and Restated Credit
Agreement, as amended as of July 7, 2009 (the Revolving Credit Facility), with Wachovia Bank,
National Association, and certain other lenders, which provides a secured revolving credit
facility in an aggregate principal amount of up to $20,000 with an initial maturity of 5 years.
We may prepay and terminate the Revolving Credit Facility at any time. The annual interest
rates applicable to loans under the Revolving Credit Facility are, at our option, either the
Alternate Base Rate or LIBOR Rate (each as defined in the Revolving Credit Facility) plus, in
each case, an applicable margin. The applicable margin is tied to our total leverage ratio (as
defined in the Revolving Credit Facility). In addition, we pay commitment fees, other fees
related to the issuance and maintenance of letters of credit, and certain agency fees.
The Revolving Credit Facility is guaranteed by and secured by substantially all of the assets of
our current and future domestic subsidiaries, subject to certain exceptions as set forth in the
Revolving Credit Facility. The Revolving Credit Facility contains certain negative covenants
restricting and limiting our ability to, among other things:
| incur debt, incur contingent obligations and issue certain types of preferred stock; | ||
| create liens; | ||
| pay dividends, distributions or make other specified restricted payments; | ||
| make certain investments and acquisitions; | ||
| enter into certain transactions with affiliates; | ||
| enter into sale and leaseback transactions; and | ||
| merge or consolidate with any other entity or sell, assign, transfer, lease, convey or otherwise dispose of assets. |
Financial covenants under the Revolving Credit Facility include quarterly requirements for total
leverage ratio of less than or equal to 5.25 to 1.00 (Total Leverage Ratio), and interest
coverage ratio of at least 2.50 to 1.00 (Interest Coverage Ratio). The Revolving Credit
Facility defines Total Leverage Ratio as the ratio of Consolidated Funded Debt to Consolidated
EBITDA and Interest Coverage Ratio as the ratio of Consolidated EBITDA to Consolidated Interest
Expense. With respect to these covenant compliance calculations, Consolidated EBITDA, as defined
in the Revolving Credit Facility (hereinafter, referred to as Credit Facility EBITDA), differs
from typical EBITDA calculations and our calculation of Adjusted EBITDA, which is used in
certain of our public releases and in connection with our incentive compensation plan. The most
significant difference in the Credit Facility EBITDA calculation is the inclusion of cash
payments for environmental remediation as part of the calculation. The following statements
summarize the elements of those definitions that are material to our computations. Consolidated
Funded Debt generally includes principal amounts outstanding under our Senior Notes, Revolving
Credit Facility, capital leases and notional amounts for outstanding letters of credit. Credit
Facility EBITDA is generally computed as consolidated net income (loss) plus income tax expense
(benefit), interest expense, depreciation and amortization, and stock-based compensation expense
and less cash payments for environmental remediation and other non-recurring gains in excess of
$50. In accordance with the definitions contained in the Revolving Credit Facility, as of
December 31, 2009, our Total Leverage Ratio was 3.86 to 1.00 and our Interest Coverage Ratio was
2.88 to 1.00.
- 11 -
Table of Contents
6. DEBT (continued)
The Revolving Credit Facility also contains usual and customary events of default (subject to
certain threshold amounts and grace periods), including cross-default provisions that include
our Senior Notes. If an event of default occurs and is continuing, we may be required to repay
the obligations under the Revolving Credit Facility prior to its stated maturity and the related
commitments may be terminated.
As of December 31, 2009, under our Revolving Credit Facility, we had no borrowings outstanding,
availability of $18,107, and we were in compliance with its various financial covenants.
Availability is computed as the total commitment of $20,000 less outstanding borrowings and
outstanding letters of credit, if any.
Letters of Credit. As of December 31, 2009, we had $1,893 in outstanding standby letters of
credit which mature through July 2013. These letters of credit principally secure performance of
certain water treatment equipment sold by us and payment of fees associated with the delivery of
natural gas and power.
7. COMMITMENTS AND CONTINGENCIES
Regulatory Review of Perchlorates. Our Specialty Chemicals segment manufactures and sells
products that contain perchlorates. Federal and state regulators continue to review the effects
of perchlorate, if any, on human health and the related allowable maximum level of contaminant
from perchlorate. While the presence of regulatory review presents general business risk to the
Company, we are currently unaware of any regulatory proposal that would have a material effect
on our results of operations and financial position or that would cause us to significantly
modify or curtail our business practices, including our remediation activities discussed below.
Perchlorate Remediation Project in Henderson, Nevada. We commercially manufactured perchlorate
chemicals at a facility in Henderson, Nevada (AMPAC Henderson Site) from 1958 until the
facility was destroyed in May 1988, after which we relocated our production to a new facility in
Iron County, Utah. Kerr-McGee Chemical Corporation (KMCC) also operated a perchlorate
production facility in Henderson, Nevada (the KMCC Site) from 1967 to 1998. In addition,
between 1956 and 1967, American Potash operated a perchlorate production facility and, for many
years prior to 1956, other entities also manufactured perchlorate chemicals at the KMCC Site.
As a result of a longer production history in Henderson, KMCC and its predecessor operations
manufactured significantly greater amounts of perchlorate over time than we did at the AMPAC
Henderson Site.
In 1997, the Southern Nevada Water Authority (SNWA) detected trace amounts of the perchlorate
anion in Lake Mead and the Las Vegas Wash. Lake Mead is a source of drinking water for Southern
Nevada and areas of Southern California. The Las Vegas Wash flows into Lake Mead from the Las
Vegas valley.
In response to this discovery by SNWA, and at the request of the Nevada Division of
Environmental Protection (NDEP), we engaged in an investigation of groundwater near the AMPAC
Henderson Site and down gradient toward the Las Vegas Wash. The investigation and related
characterization, which lasted more than six years, employed experts in the field of
hydrogeology. This investigation concluded that although there is perchlorate in the groundwater
in the vicinity of the AMPAC Henderson Site up to 700 parts per million, perchlorate from this
site does not materially impact, if at all, water flowing in the Las Vegas Wash toward Lake
Mead. It has been well established, however, by data generated by SNWA and NDEP, that
perchlorate from the KMCC Site did impact the Las Vegas Wash and Lake Mead. KMCCs successor,
Tronox LLC, operates an above ground perchlorate groundwater remediation facility at their
Henderson site. Recent measurements of perchlorate in Lake Mead made by SNWA have been less than
10 parts per billion.
- 12 -
Table of Contents
7. COMMITMENTS AND CONTINGENCIES (Continued)
Notwithstanding these facts, and at the direction of NDEP and the U.S. Environmental Protection
Agency (the EPA), we conducted an investigation of remediation technologies for perchlorate in
groundwater with the intention of remediating groundwater near the AMPAC Henderson Site. The
technology that was chosen as most efficient and appropriate was in situ bioremediation (ISB).
ISB reduces perchlorate in the groundwater by precise addition of an appropriate carbon source
to the groundwater itself while it is still in the ground (as opposed to an above ground, more
conventional, ex situ process). This induces naturally occurring organisms in the groundwater
to reduce the perchlorate among other oxygen containing compounds.
In 2002, we conducted a pilot test in the field of the ISB technology and it was successful. On
the basis of the successful test and other evaluations, in the fiscal year ended September 30,
2005 (Fiscal 2005), we submitted a work plan to NDEP for the construction of a remediation
facility near the AMPAC Henderson Site. The conditional approval of the work plan by NDEP in
our third quarter of Fiscal 2005 allowed us to generate estimated costs for the installation and
operation of the remediation facility to address perchlorate at the AMPAC Henderson Site. We
commenced construction in July 2005. In December 2006, we began operations. The location of
this facility is several miles, in the direction of groundwater flow, from the AMPAC Henderson
Site.
At the request of the NDEP, we recently renewed discussions to formalize our remediation efforts
in a voluntary agreement that, if negotiated and executed, would provide more detailed
regulatory guidance on environmental characterization and remedies at the AMPAC Henderson Site
and vicinity. The agreement under discussion would be expected to be similar to others
previously executed by the NDEP with other companies under similar circumstances. Typically,
such agreements generally cover such matters as the scope of work plans, schedules,
deliverables, remedies for non compliance, and reimbursement to the State of Nevada for past and
future oversight.
Henderson Site Environmental Remediation Reserve. We accrue for anticipated costs associated
with environmental remediation that are probable and estimable. On a quarterly basis, we review
our estimates of future costs that could be incurred for remediation activities. In some cases,
only a range of reasonably possible costs can be estimated. In establishing our reserves, the
most probable estimate is used; otherwise, we accrue the minimum amount of the range.
During our Fiscal 2005 third quarter, we recorded a charge for $22,400 representing our estimate
of the probable costs of our remediation efforts at the AMPAC Henderson Site, including the
costs for capital equipment, operating and maintenance (O&M), and consultants. The project
consisted of two primary phases: the initial construction of the remediation equipment phase and
the O&M phase. During the fiscal year ended September 30, 2006, we increased our total cost
estimate of probable costs for the construction phase by $3,600 due primarily to changes in the
engineering designs, delays in receiving permits and the resulting extension of construction
time.
ISB is a new technology on the scale being used at the AMPAC Henderson Site. Accordingly, as we
gain ISB operational experience, we have been and are observing certain conditions, operating
results and other data which we consider in updating the assumptions used to determine our cost
estimates. The two most significant assumptions are the estimated speed of groundwater flowing
to our remediation extraction wells and the estimated annual O&M costs.
Late in the fiscal year ended September 30, 2009 (Fiscal 2009), we gained additional
information from groundwater modeling that indicates groundwater emanating from the AMPAC
Henderson Site in certain areas in deeper zones (more than 150 feet below ground surface) is
moving toward our existing remediation facility at a much slower pace than previously estimated.
Utilization of our existing facilities alone, at this lower groundwater pace, could, according
to this recently created groundwater model, extend the life of our remediation project to well
in excess of fifty years. As a result of this additional data, we re-evaluated our remediation
operations. This evaluation indicates
- 13 -
Table of Contents
7. COMMITMENTS AND CONTINGENCIES (Continued)
that we should be able to significantly reduce the total
project time, and ultimately the total cost of the project, by installing additional groundwater extraction wells in the deeper, more concentrated
areas, thereby providing for a more aggressive remediation treatment. The additional wells and
related remediation equipment will incorporate above ground treatment to supplement or possibly
replace by consolidation our existing ISB process. With the additional extraction wells and
equipment, we estimate that the total remaining project life for the existing and new, more
aggressive deep zone systems could range from 10 to 29 years, beginning with the fiscal year
ending September 30, 2010 (Fiscal 2010). Within that range, we estimate that a range of 13 to
23 years is more likely. Groundwater speed, perchlorate concentrations, aquifer characteristics
and forecasted groundwater extraction rates continue to be key variables underlying our estimate
of the life of the project. If additional information becomes available in the future that is
different than information currently available to us, our estimate of the resulting project life
could change significantly.
In our Fiscal 2009 fourth quarter, we accrued approximately $9,600 representing our estimate of
the cost to engineer, design, and install this additional equipment. We anticipate that these
amounts will be spent through and the new equipment operational in
approximately fall 2011. However, because
we are in the early design and engineering steps, this estimate involves a number of significant
assumptions. Due to uncertainties inherent in making early stage estimates, our estimate may
later require significant revision as new facts become available and circumstances change.
In addition to accruing approximately $9,600 for engineering, design, installation and cost of
additional equipment, in our Fiscal 2009 fourth quarter, we increased our estimate of total
remaining O&M costs by $4,100 due primarily to incremental O&M costs to operate and maintain the
additional equipment once installed. Total O&M expenses are currently estimated at approximately
$1,000 per year and estimated to increase to approximately $1,300 per year after the additional
equipment becomes operational. To estimate O&M costs, we consider, among other factors, the
project scope and historical expense rates to develop assumptions regarding labor, utilities,
repairs, maintenance supplies and professional service costs. If additional information becomes
available in the future that is different than information currently available to us and thereby
lead us to different conclusions, our estimate of O&M expenses could change significantly.
In addition, certain remediation activities are conducted on public lands under operating
permits. In general, these permits require us to return the land to its original condition at
the end of the permit period. Estimated costs associated with removal of remediation equipment
from the land are not material and are included in our range of estimated costs.
As of December 31, 2009, the aggregate range of anticipated environmental remediation costs was
from approximately $22,300 to approximately $46,500 based on a possible total remaining life of
the project ranging from 10 to 29 years. The accrued amount was $26,008, based on 13 years
(beginning with Fiscal 2010), or the low end of the more likely range of 13 to 23 years as no
amount within the range was more likely. These estimates are based on information currently
available to us and may be subject to material adjustment upward or downward in future periods
as new facts or circumstances may indicate. A summary of our environmental reserve activity for
the three months ended December 31, 2009 is shown below:
Balance, September 30, 2009 |
$ | 26,690 | ||
Additions or adjustments |
| |||
Expenditures |
(682 | ) | ||
Balance, December 31, 2009 |
$ | 26,008 | ||
AFC Environmental Matters. Our Fine Chemicals segment, Ampac Fine Chemicals LLC (AFC),
is located on land leased from Aerojet-General Corporation (Aerojet). The leased land is part
of a tract of land owned by Aerojet designated as a Superfund site under the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA). The tract of land
had been used by
Aerojet and affiliated companies to manufacture and test rockets and related equipment since the
1950s. Although the chemicals identified as contaminants on the leased land were not used by
- 14 -
Table of Contents
7. COMMITMENTS AND CONTINGENCIES (Continued)
Aerojet Fine Chemicals LLC (predecessor in interest to AFC) as part of its operations, CERCLA,
among other things, provides for joint and severable liability for environmental liabilities
including, for example, environmental remediation expenses.
As part of the agreement by which we acquired the business of AFC from GenCorp Inc. (GenCorp),
an Environmental Indemnity Agreement was entered into whereby GenCorp agreed to indemnify us
against any and all environmental costs and liabilities arising out of or resulting from any
violation of environmental law prior to the effective date of the sale, or any release of
hazardous substances by Aerojet Fine Chemicals LLC, Aerojet or GenCorp on the AFC premises or
Aerojets Sacramento site prior to the effective date of the sale.
On November 29, 2005, EPA Region IX provided us with a letter indicating that the EPA does not
intend to pursue any clean up or enforcement actions under CERCLA against future lessees of the
Aerojet property for existing contamination, provided that the lessees do not contribute to or
do not exacerbate existing contamination on or under the Aerojet Superfund site.
Other Matters. Although we are not currently party to any material pending legal proceedings,
we are from time to time subject to claims and lawsuits related to our business operations. We
accrue for loss contingencies when a loss is probable and the amount can be reasonably
estimated. Legal fees, which can be material in any given period, are expensed as incurred. We
believe that current claims or lawsuits against us, individually and in the aggregate, will not
result in loss contingencies that will have a material adverse effect on our financial
condition, cash flows or results of operations.
8. SEGMENT INFORMATION
We report our business in four operating segments: Fine Chemicals, Specialty Chemicals,
Aerospace Equipment and Other Businesses. These segments are based upon business units that
offer distinct products and services, are operationally managed separately and produce products
using different production methods. Segment operating income or loss includes all sales and
expenses directly associated with each segment. Environmental remediation charges, corporate
general and administrative costs, which consist primarily of executive, investor relations,
accounting, human resources and information technology expenses, and interest are not allocated
to segment operating results.
Fine Chemicals. Our Fine Chemicals segment includes the operating results of our wholly-owned
subsidiary Ampac Fine Chemicals LLC or AFC. AFC is a custom manufacturer of active
pharmaceutical ingredients and registered intermediates for commercial customers in the
pharmaceutical industry. AFC operates in compliance with the U.S. Food and Drug Administrations
current Good Manufacturing Practices and other regulatory agencies such as the European Unions
European Medicines Agency and Japans Pharmaceuticals and Medical Devices Agency. AFC has
distinctive competencies and specialized engineering capabilities in performing chiral
separations, manufacturing chemical compounds that require high containment and performing
energetic chemistries at commercial scale.
Specialty Chemicals. Our Specialty Chemicals segment manufactures and sells: (i) perchlorate
chemicals, principally ammonium perchlorate, which is the predominant oxidizing agent for solid
propellant rockets, booster motors and missiles used in space exploration, commercial satellite
transportation and national defense programs, (ii) sodium azide, a chemical used in
pharmaceutical manufacturing, and (iii) Halotronâ, a series of clean fire extinguishing
agents used in fire extinguishing products ranging from portable fire extinguishers to total
flooding systems.
- 15 -
Table of Contents
8. SEGMENT INFORMATION (Continued)
Aerospace Equipment. Our Aerospace Equipment segment includes the operating results of our
wholly-owned subsidiary Ampac-ISP Corp. and its wholly-owned subsidiaries (collectively, AMPAC
ISP). AMPAC ISP manufactures monopropellant and bipropellant
liquid propulsion systems and thrusters for satellites, launch vehicles, and interceptors. In addition, AMPAC ISP designs,
develops and manufactures high performance valves, pressure regulators, cold-gas propulsion
systems, and precision structures for space applications, especially in the European space
market.
Other Businesses. Our Other Businesses segment contains our water treatment equipment and real
estate activities. Our water treatment equipment business designs, manufactures and markets
systems for the control of noxious odors, the disinfection of water streams and the treatment of
seawater. Our real estate activities are not material.
Our revenues are characterized by individually significant orders and relatively few customers.
As a result, in any given reporting period, certain customers may account for more than ten
percent of our consolidated revenues.
The following table provides disclosure of the percentage of our consolidated revenues
attributed to customers that exceed ten percent of the total in each of the given periods.
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Fine chemicals customer |
25 | % | ||||||
Fine chemicals customer |
15 | % | ||||||
Fine chemicals customer |
10 | % | ||||||
Specialty chemicals customer |
28 | % | 29 | % |
The following provides financial information about our segment operations:
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Revenues: |
||||||||
Fine Chemicals |
$ | 9,504 | $ | 20,384 | ||||
Specialty Chemicals |
12,803 | 17,359 | ||||||
Aerospace Equipment |
8,325 | 5,756 | ||||||
Other Businesses |
3,432 | 2,130 | ||||||
Total Revenues |
$ | 34,064 | $ | 45,629 | ||||
Segment Operating Income (Loss): |
||||||||
Fine Chemicals |
$ | (740 | ) | $ | (1,024 | ) | ||
Specialty Chemicals |
5,831 | 7,606 | ||||||
Aerospace Equipment |
(362 | ) | 410 | |||||
Other Businesses |
(17 | ) | 545 | |||||
Total Segment Operating Income |
4,712 | 7,537 | ||||||
Corporate Expenses |
(4,573 | ) | (4,112 | ) | ||||
Operating Income (Loss) |
$ | 139 | $ | 3,425 | ||||
Depreciation and Amortization: |
||||||||
Fine Chemicals |
$ | 3,328 | $ | 3,208 | ||||
Specialty Chemicals |
171 | 304 | ||||||
Aerospace Equipment |
423 | 331 | ||||||
Other Businesses |
4 | 3 | ||||||
Corporate |
127 | 123 | ||||||
Total Depreciation and Amortization |
$ | 4,053 | $ | 3,969 | ||||
- 16 -
Table of Contents
9. INCOME TAXES
We review our portfolio of uncertain tax positions and recorded liabilities based on the
applicable recognition standards. In this regard, an uncertain tax position represents our
expected treatment of a tax position taken in a filed tax return, or planned to be taken in a
future tax return, that has not been reflected in measuring income tax expense for financial
reporting purposes. We classify uncertain tax positions as non-current income tax liabilities
unless expected to be settled within one year.
As of both December 31, 2009 and September 30, 2009, our recorded liability for unrecognized tax
benefits was $652, of which $335 would affect our effective tax rate, if recognized. The
remaining balance is related to deferred tax items which only impact the timing of tax payments.
In Fiscal 2010, it is reasonably possible that the gross liability for unrecognized tax benefits
will decrease by $323 primarily as a result of a change in accounting methods for tax purposes
and the lapsing of statutes of limitations.
We recognize accrued interest and penalties related to unrecognized tax benefits in income tax
expense. As of December 31, 2009 and September 30, 2009, we had accrued $166 and $164,
respectively, for the payment of tax-related interest and penalties. For the three months ended
December 31, 2009 and 2008, income tax (benefit) expense includes a benefit of $8 and expense of
$2 for interest and penalties.
We file income tax returns in the U.S. federal jurisdiction, various states, and foreign
jurisdictions. With few exceptions, we are no longer subject to federal or state income tax
examinations for years before 2006.
10. DEFINED BENEFIT PLANS
We maintain three defined benefit pension plans which cover substantially all of our U.S.
employees, excluding employees of our Aerospace Equipment segment: the Amended and Restated
American Pacific Corporation Defined Benefit Pension Plan, the Ampac Fine Chemicals LLC Pension
Plan for Salaried Employees, and the Ampac Fine Chemicals LLC Pension Plan for Bargaining Unit
Employees, each as amended and restated (collectively, the Pension Plans). In addition, we
maintain the American Pacific Corporation Supplemental Executive Retirement Plan, as amended and
restated (the SERP), which includes certain of our existing and prior executive officers.
We maintain two 401(k) plans in which participating employees may make contributions. One covers
substantially all U.S. employees except AFC bargaining unit employees and the other covers AFC
bargaining unit employees. We make matching contributions for
employees of AFC and U.S. employees of our Aerospace Equipment segment. In addition, we make a profit sharing
contribution for U.S. employees of our Aerospace Equipment segment.
We provide healthcare and life insurance benefits to substantially all of our employees.
- 17 -
Table of Contents
10. DEFINED BENEFIT PLANS (Continued)
Net periodic pension cost consists of the following:
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Pension Plans: |
||||||||
Service Cost |
$ | 625 | $ | 507 | ||||
Interest Cost |
798 | 670 | ||||||
Expected Return on Plan Assets |
(603 | ) | (601 | ) | ||||
Recognized Actuarial Losses |
263 | 109 | ||||||
Amortization of Prior Service Costs |
19 | 19 | ||||||
Net Periodic Pension Cost |
$ | 1,102 | $ | 704 | ||||
Supplemental Executive Retirement Plan: |
||||||||
Service Cost |
$ | 110 | $ | 98 | ||||
Interest Cost |
93 | 102 | ||||||
Expected Return on Plan Assets |
| |||||||
Recognized Actuarial Losses |
| |||||||
Amortization of Prior Service Costs |
105 | 105 | ||||||
Net Periodic Pension Cost |
$ | 308 | $ | 305 | ||||
For the three months ended December 31, 2009, we contributed $527 to the Pension Plans to
fund benefit payments and anticipate making approximately $2,041 in additional contributions
through September 30, 2010. For the three months ended December 31, 2009, we contributed $32 to
the SERP to fund benefit payments and anticipate making approximately $450 in additional
contributions through September 30, 2010.
- 18 -
Table of Contents
11. GUARANTOR SUBSIDIARIES
As discussed in Note 6, in February 2007, American Pacific Corporation, a Delaware corporation
(Parent) issued and sold $110,000 aggregate principal amount of Senior Notes. In connection
with the issuance of the Senior Notes, the Parents U.S. subsidiaries (Guarantor Subsidiaries)
jointly, fully, severally, and unconditionally guaranteed the Senior Notes. The Parents foreign
subsidiaries (Non-Guarantor Subsidiaries) are not guarantors of the Senior Notes. Each of the
Parents subsidiaries is 100% owned. The Parent has no independent assets or operations. The
following presents condensed consolidating financial information separately for the Parent,
Guarantor Subsidiaries and Non-Guarantor Subsidiaries.
Condensed Consolidating Balance Sheet December 31, 2009
Guarantor | Non-Guarantor | |||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Assets: |
||||||||||||||||||||
Cash and Cash Equivalents |
$ | | $ | 36,903 | $ | 1,716 | $ | | $ | 38,619 | ||||||||||
Accounts Receivable, Net |
| 20,587 | 3,565 | (263 | ) | 23,889 | ||||||||||||||
Inventories |
| 46,466 | 1,317 | | 47,783 | |||||||||||||||
Prepaid Expenses and Other Assets |
| 2,273 | 80 | | 2,353 | |||||||||||||||
Income Taxes Receivable and Deferred Income Taxes |
| 8,756 | | | 8,756 | |||||||||||||||
Total Current Assets |
| 114,985 | 6,678 | (263 | ) | 121,400 | ||||||||||||||
Property, Plant and Equipment, Net |
| 111,110 | 1,524 | | 112,634 | |||||||||||||||
Intangible Assets, Net |
| 1,465 | 1,540 | | 3,005 | |||||||||||||||
Goodwill |
| | 3,088 | | 3,088 | |||||||||||||||
Deferred Income Taxes |
| 21,122 | | | 21,122 | |||||||||||||||
Other Assets |
| 10,150 | | | 10,150 | |||||||||||||||
Intercompany Advances |
79,918 | 2,879 | | (82,797 | ) | | ||||||||||||||
Investment in Subsidiaries, Net |
100,010 | 5,827 | | (105,837 | ) | | ||||||||||||||
Total Assets |
$ | 179,928 | $ | 267,538 | $ | 12,830 | $ | (188,897 | ) | $ | 271,399 | |||||||||
Liabilitites and Stockholders Equity: |
||||||||||||||||||||
Accounts Payable and Other Current Liabilities |
$ | | $ | 23,354 | $ | 1,818 | $ | (263 | ) | $ | 24,909 | |||||||||
Environmental Remediation Reserves |
| 2,110 | | | 2,110 | |||||||||||||||
Deferred Revenues and Customer Deposits |
| 9,016 | 2,085 | | 11,101 | |||||||||||||||
Current Portion of Long-Term Debt |
| 69 | 52 | | 121 | |||||||||||||||
Intercompany Advances |
| 79,918 | 2,879 | (82,797 | ) | | ||||||||||||||
Total Current Liabilities |
| 114,467 | 6,834 | (83,060 | ) | 38,241 | ||||||||||||||
Long-Term Debt |
110,000 | 48 | 83 | | 110,131 | |||||||||||||||
Environmental Remediation Reserves |
| 23,898 | | | 23,898 | |||||||||||||||
Pension Obligations and Other Long-Term Liabilities |
| 29,115 | 86 | | 29,201 | |||||||||||||||
Total Liabilities |
110,000 | 167,528 | 7,003 | (83,060 | ) | 201,471 | ||||||||||||||
Total Shareholders Equity |
69,928 | 100,010 | 5,827 | (105,837 | ) | 69,928 | ||||||||||||||
Total Liabilities and Shareholders Equity |
$ | 179,928 | $ | 267,538 | $ | 12,830 | $ | (188,897 | ) | $ | 271,399 | |||||||||
- 19 -
Table of Contents
11. GUARANTOR SUBSIDIARIES (Continued)
Condensed Consolidating Balance Sheet September
30, 2009
Guarantor | Non-Guarantor | |||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Assets: |
||||||||||||||||||||
Cash and Cash Equivalents |
$ | | $ | 20,046 | $ | 1,635 | $ | | $ | 21,681 | ||||||||||
Accounts Receivable, Net |
| 40,399 | 3,951 | (322 | ) | 44,028 | ||||||||||||||
Inventories |
| 35,223 | 1,133 | | 36,356 | |||||||||||||||
Prepaid Expenses and Other Assets |
| 1,645 | 166 | | 1,811 | |||||||||||||||
Income Taxes Receivable and Deferred Income Taxes |
| 8,465 | | | 8,465 | |||||||||||||||
Total Current Assets |
| 105,778 | 6,885 | (322 | ) | 112,341 | ||||||||||||||
Property, Plant and Equipment, Net |
| 113,143 | 1,502 | | 114,645 | |||||||||||||||
Intangible Assets, Net |
| 1,775 | 1,778 | | 3,553 | |||||||||||||||
Goodwill |
| | 3,144 | | 3,144 | |||||||||||||||
Deferred Income Taxes |
| 21,121 | | | 21,121 | |||||||||||||||
Other Assets |
| 10,037 | | | 10,037 | |||||||||||||||
Intercompany Advances |
79,918 | 2,535 | | (82,453 | ) | | ||||||||||||||
Investment in Subsidiaries, Net |
101,179 | 6,229 | | (107,408 | ) | | ||||||||||||||
Total Assets |
$ | 181,097 | $ | 260,618 | $ | 13,309 | $ | (190,183 | ) | $ | 264,841 | |||||||||
Liabilitites and Stockholders Equity: |
||||||||||||||||||||
Accounts Payable and Other Current Liabilities |
$ | | $ | 19,894 | $ | 1,936 | $ | (322 | ) | $ | 21,508 | |||||||||
Environmental Remediation Reserves |
| 2,522 | | | 2,522 | |||||||||||||||
Deferred Revenues and Customer Deposits |
| 4,579 | 2,332 | | 6,911 | |||||||||||||||
Current Portion of Long-Term Debt |
| 99 | 52 | | 151 | |||||||||||||||
Intercompany Advances |
| 79,918 | 2,535 | (82,453 | ) | | ||||||||||||||
Total Current Liabilities |
| 107,012 | 6,855 | (82,775 | ) | 31,092 | ||||||||||||||
Long-Term Debt |
110,000 | | 97 | | 110,097 | |||||||||||||||
Environmental Remediation Reserves |
| 24,168 | | | 24,168 | |||||||||||||||
Pension Obligations and Other Long-Term Liabilities |
| 28,259 | 128 | | 28,387 | |||||||||||||||
Total Liabilities |
110,000 | 159,439 | 7,080 | (82,775 | ) | 193,744 | ||||||||||||||
Total Shareholders Equity |
71,097 | 101,179 | 6,229 | (107,408 | ) | 71,097 | ||||||||||||||
Total Liabilities and Shareholders Equity |
$ | 181,097 | $ | 260,618 | $ | 13,309 | $ | (190,183 | ) | $ | 264,841 | |||||||||
Condensed Consolidating Statement
of Operations Three Months Ended
December 31, 2009
Guarantor | Non-Guarantor | |||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Revenues |
$ | | $ | 31,728 | $ | 2,503 | $ | (167 | ) | $ | 34,064 | |||||||||
Cost of Revenues |
| 20,012 | 1,773 | (167 | ) | 21,618 | ||||||||||||||
Gross Profit |
| 11,716 | 730 | | 12,446 | |||||||||||||||
Operating Expenses |
| 11,257 | 1,050 | | 12,307 | |||||||||||||||
Operating Income (Loss) |
| 459 | (320 | ) | | 139 | ||||||||||||||
Interest and Other Income |
2,669 | 40 | (48 | ) | (2,669 | ) | (8 | ) | ||||||||||||
Interest Expense |
2,669 | 2,689 | 2 | (2,669 | ) | 2,691 | ||||||||||||||
Loss before Income Tax and Equity Account for Subsidiaries |
| (2,190 | ) | (370 | ) | | (2,560 | ) | ||||||||||||
Income Tax Benefit |
| (1,077 | ) | (43 | ) | | (1,120 | ) | ||||||||||||
Loss before Equity Account for Subsidiaries |
| (1,113 | ) | (327 | ) | | (1,440 | ) | ||||||||||||
Equity Account for Subsidiaries |
(1,440 | ) | (327 | ) | | 1,767 | | |||||||||||||
Net Loss |
$ | (1,440 | ) | $ | (1,440 | ) | $ | (327 | ) | $ | 1,767 | $ | (1,440 | ) | ||||||
- 20 -
Table of Contents
11. GUARANTOR SUBSIDIARIES (Continued)
Condensed Consolidating Statement
of Operations Three Months Ended
December 31, 2008
Guarantor | Non-Guarantor | |||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Revenues |
$ | | $ | 43,902 | $ | 1,745 | $ | (18 | ) | $ | 45,629 | |||||||||
Cost of Revenues |
| 29,809 | 1,104 | (18 | ) | 30,895 | ||||||||||||||
Gross Profit |
| 14,093 | 641 | | 14,734 | |||||||||||||||
Operating Expenses |
| 10,711 | 598 | | 11,309 | |||||||||||||||
Operating Income |
| 3,382 | 43 | | 3,425 | |||||||||||||||
Interest and Other Income |
2,668 | 89 | 1 | (2,668 | ) | 90 | ||||||||||||||
Interest Expense |
2,668 | 2,686 | 37 | (2,668 | ) | 2,723 | ||||||||||||||
Income
before Income Tax and Equity Account for Subsidiaries |
| 785 | 7 | | 792 | |||||||||||||||
Income Tax Expense |
| 335 | | | 335 | |||||||||||||||
Income
before Equity Account for Subsidiaries |
| 450 | 7 | | 457 | |||||||||||||||
Equity Account for Subsidiaries |
457 | 7 | | (464 | ) | | ||||||||||||||
Net Income |
$ | 457 | $ | 457 | $ | 7 | $ | (464 | ) | $ | 457 | |||||||||
Condensed Consolidating Statement of Cash Flows
Three Months Ended December 31, 2009
Guarantor | Non-Guarantor | |||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Net Cash Provided (Used) by Operating Activities |
$ | | $ | 18,205 | $ | (98 | ) | $ | | $ | 18,107 | |||||||||
Cash Flows from Investing Activities: |
||||||||||||||||||||
Capital expenditures |
| (957 | ) | (142 | ) | | (1,099 | ) | ||||||||||||
Net Cash Used in Investing Activities |
| (957 | ) | (142 | ) | | (1,099 | ) | ||||||||||||
Cash Flows from Financing Activities: |
||||||||||||||||||||
Payments of long-term debt |
| (47 | ) | (12 | ) | | (59 | ) | ||||||||||||
Intercompany advances, net |
| (344 | ) | 344 | | | ||||||||||||||
Net Cash Provided (Used) by Financing Activities |
| (391 | ) | 332 | | (59 | ) | |||||||||||||
Effect of Changes in Currency Exchange Rates |
| | (11 | ) | (11 | ) | ||||||||||||||
Net Change in Cash and Cash Equivalents |
| 16,857 | 81 | | 16,938 | |||||||||||||||
Cash and Cash Equivalents, Beginning of Period |
| 20,046 | 1,635 | | 21,681 | |||||||||||||||
Cash and Cash Equivalents, End of Period |
$ | | $ | 36,903 | $ | 1,716 | $ | | $ | 38,619 | ||||||||||
Condensed Consolidating Statement of Cash
Flows Three Months Ended December 31, 2008
Guarantor | Non-Guarantor | |||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Net Cash Provided by Operating Activities |
$ | | $ | 5,535 | $ | 1,415 | $ | | $ | 6,950 | ||||||||||
Cash Flows from Investing Activities: |
||||||||||||||||||||
Capital expenditures |
| (1,626 | ) | (183 | ) | | (1,809 | ) | ||||||||||||
Acquisition on business, net of cash acquired |
| (7,132 | ) | 479 | | (6,653 | ) | |||||||||||||
Net Cash Used in Investing Activities |
| (8,758 | ) | 296 | | (8,462 | ) | |||||||||||||
Cash Flows from Financing Activities: |
||||||||||||||||||||
Payments of long-term debt |
| (84 | ) | (24 | ) | | (108 | ) | ||||||||||||
Issuance of common stock |
32 | | | | 32 | |||||||||||||||
Excess tax benefit from exrecise of stock options |
3 | | | | 3 | |||||||||||||||
Intercompany advances, net |
(35 | ) | (363 | ) | 398 | | | |||||||||||||
Net Cash Provided by Financing Activities |
| (447 | ) | 374 | | (73 | ) | |||||||||||||
Net Change in Cash and Cash Equivalents |
| (3,670 | ) | 2,085 | | (1,585 | ) | |||||||||||||
Cash and Cash Equivalents, Beginning of Period |
| 26,664 | 229 | | 26,893 | |||||||||||||||
Cash and Cash Equivalents, End of Period |
$ | | $ | 22,994 | $ | 2,314 | $ | | $ | 25,308 | ||||||||||
- 21 -
Table of Contents
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(Dollars in Thousands)
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended, which are subject to the safe harbor created by those sections. These
forward-looking statements include, but are not limited to: our expectations regarding working
capital and related variances in the future, our potential incurrence of additional debt in the
future, our belief that our cash flows and existing debt will be adequate for the foreseeable
future to satisfy the needs of our operations, our expectations regarding anticipated contributions
and obligations with respect to our defined benefit pension plans and supplemental executive
retirement plan, our estimates and expectations regarding anticipated cash expenditures for
environmental remediation at our former Henderson, Nevada site, our expectations regarding future
compliance with debt covenants, statements regarding future price, manufacturing costs and demand
for, and related volume of, perchlorate products and the impact on
forecasted future revenues, our statement regarding one of the significant
factors that will affect our consolidated gross margins in the future, our expectation regarding
revenues from our Fine Chemicals segment for the current fiscal year, our
expectations regarding fulfillment of existing backlog within the
next twelve months, our anticipated capital expenditures for the
current fiscal year, and all
plans, objectives, expectations and intentions contained in this report that are not historical
facts. We usually use words such as may, can, will, could, should, expect,
anticipate, believe, estimate, or future, or the negative of these terms or similar
expressions to identify forward-looking statements. Discussions containing such forward-looking
statements may be found throughout this document. These forward-looking statements involve certain
risks and uncertainties that could cause actual results to differ materially from future results or
outcomes expressed or implied in such forward-looking statements. Please see the section titled
Risk Factors in Part II, Item 1A of this Quarterly Report on Form 10-Q for further discussion of
factors that could affect future results. All forward-looking statements in this document are made
as of the date hereof, based on information available to us as of the date hereof, and we assume no
obligation to update any forward-looking statement, unless otherwise required by law. Any business
risks discussed later in this Item 2, among other things, should be considered in evaluating our
prospects and future financial performance.
The terms Company, we, us, and our are used herein to refer to American Pacific Corporation
and, where the context requires, one or more of the direct and indirect subsidiaries or divisions
of American Pacific Corporation. The following discussion and analysis is intended to provide a
narrative discussion of our financial results and an evaluation of our financial condition and
results of operations with respect to the first fiscal quarter of the year ending September 30,
2010 (Fiscal 2010) as compared to the first fiscal quarter of the year ended September 30, 2009
(Fiscal 2009). The discussion should be read in conjunction with our Annual Report on Form 10-K
for Fiscal 2009 filed with the Securities and Exchange Commission (the SEC) and the condensed
consolidated financial statements and notes thereto included elsewhere in this Quarterly Report on
Form 10-Q. A summary of our significant accounting policies is included in Note 1 to our
consolidated financial statements in our Annual Report on Form 10-K for Fiscal 2009.
OUR COMPANY
We are a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion
products within our focused markets. We supply active pharmaceutical ingredients (APIs) and
advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we
provide specialty chemicals used in solid rocket motors for space launch and military missiles. We
also design and manufacture liquid propulsion systems, valves and structures for space and missile
defense applications. We produce clean agent chemicals for the fire protection industry, as well
as electro-chemical equipment for the water treatment industry. Our technical and manufacturing
expertise and customer service focus has gained us a reputation for quality, reliability, technical
performance and innovation. Given the mission critical nature of our products, we maintain
long-standing strategic customer relationships. We work collaboratively with our customers to
develop customized solutions that meet rigorous federal and international regulatory standards. We
generally sell our products through long-term contracts under which we are the sole-source or
limited-source supplier.
- 22 -
Table of Contents
OUR BUSINESS SEGMENTS
Our operations comprise four reportable business segments: (i) Fine Chemicals, (ii) Specialty
Chemicals, (iii) Aerospace Equipment and (iv) Other Businesses. The following table reflects the
revenue contribution percentage from our business segments and each of their major product lines:
Three Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Fine Chemicals |
28 | % | 45 | % | ||||
Specialty Chemicals: |
||||||||
Perchlorates |
32 | % | 35 | % | ||||
Sodium Azide |
3 | % | 1 | % | ||||
Halotron |
3 | % | 2 | % | ||||
Total Specialty Chemicals |
38 | % | 38 | % | ||||
Aerospace Equipment |
24 | % | 13 | % | ||||
Other Businesses: |
||||||||
Real Estate |
0 | %* | 1 | % | ||||
Water Treatment Equipment |
10 | % | 3 | % | ||||
Total Other Businesses |
10 | % | 4 | % | ||||
Total Revenues |
100 | % | 100 | % | ||||
* | less than 1% |
FINE CHEMICALS. Our Fine Chemicals segment, operated through our wholly-owned subsidiary
Ampac Fine Chemicals LLC (AFC), is a custom manufacturer of APIs and registered intermediates for
commercial customers in the pharmaceutical industry. The pharmaceutical ingredients we manufacture
are used by our customers in drugs with indications in three primary areas: anti-viral, oncology,
and central nervous system. We generate nearly all of our Fine
Chemicals segment sales from manufacturing
chemical compounds that are proprietary to our customers. We operate in compliance with the U.S.
Food and Drug Administrations (the FDA) current Good Manufacturing Practices (cGMP) and other
regulatory agencies such as the European Unions European Medicines Agency and Japans
Pharmaceuticals and Medical Devices Agency. Our Fine Chemicals segments strategy is to focus on
high growth markets where our technological position, combined with our chemical process
development and engineering expertise, leads to strong customer allegiances and limited
competition.
We have distinctive competencies and specialized engineering capabilities in performing chiral
separations, manufacturing chemical compounds that require high containment and performing
energetic chemistries at commercial scale. We have invested significant resources in our facilities
and technology base. We believe we are the U.S. leader in performing chiral separations using
commercial-scale simulated moving bed, or SMB, technology and own and operate two large-scale SMB
machines, both of which are among the largest in the world operating under cGMP. We believe our
distinctive competency in manufacturing chemical compounds that require specialized high
containment facilities and handling expertise provide us a significant competitive advantage in
competing for various opportunities associated with high potency, highly toxic and cytotoxic
products. Many oncology drugs are made with APIs that are high potency or cytotoxic. AFC is one of
the few companies in the world that can manufacture such compounds at a multi-ton annual rate.
Moreover, our significant experience and specially engineered facilities make us one of the few
companies in the world with the capability to use energetic chemistry on a commercial-scale under
cGMP. We use this capability in development and production of products such as those used in
anti-viral drugs, including HIV-related and influenza-combating drugs.
We have established long-term, sole-source and limited-source contracts, which help provide us with
earnings stability and visibility. In addition, the inherent nature of custom pharmaceutical fine
chemicals manufacturing encourages stable, long-term customer relationships. We work
collaboratively with our customers to develop reliable, safe and cost-effective, custom solutions.
Once a custom manufacturer
- 23 -
Table of Contents
has been qualified as a supplier on a cGMP product, there are several
potential barriers that discourage transferring the manufacturing of the product to an alternative
supplier, including the following:
| Alternative Supply May Not Be Readily Available. We are currently the sole-source supplier on several of our fine chemicals products. | |
| Regulatory Approval. Applications to and approvals from the FDA and other regulatory authorities generally require the chemical contractor to be named. Switching contractors may require additional regulatory approvals and could take as long as two years to complete. | |
| Significant Financial Costs. Switching contractors and amending various filings can result in significant costs associated with technology transfer, process validation and re-filing with the FDA and other regulatory authorities. |
SPECIALTY CHEMICALS. Our Specialty Chemicals segment is principally engaged in the production of
ammonium perchlorate (AP), which is the predominant oxidizing agent for solid propellant rockets,
booster motors and missiles used in space exploration, commercial satellite transportation and
national defense programs. In addition, we produce and sell sodium azide, a chemical used in
pharmaceutical manufacturing, and Halotron®, a series of clean fire extinguishing agents used in
fire extinguishing products ranging from portable fire extinguishers to total flooding systems.
We have supplied AP for use in space and defense programs for over 50 years and we have been the
only AP supplier in North America since 1998, when we acquired the AP business of our principal
competitor, Kerr-McGee Chemical Corporation. A significant number of existing and planned space
launch vehicles use solid propellant and thus depend, in part, upon our AP. Many of the rockets and
missiles used in national defense programs are also powered by solid propellant.
Alliant Techsystems Inc. or ATK is a significant AP customer. We sell Grade I AP to ATK under a
long-term contract that requires us to maintain a ready and qualified capacity for Grade I AP and
that requires ATK to purchase its Grade I AP requirements from us, subject to certain terms and
conditions. The contract, which expires in 2013, provides fixed pricing in the form of a price
volume matrix for annual Grade I AP volumes ranging from 3 million to 20 million pounds. Pricing
varies inversely to volume and includes annual escalations.
AEROSPACE EQUIPMENT. Our Aerospace Equipment segment reflects the operating results of our
wholly-owned subsidiary Ampac-ISP Corp. and its wholly-owned subsidiaries (AMPAC ISP).
Our U.S.-based Aerospace Equipment operation is one of two major North American manufacturers of
monopropellant and bipropellant liquid propulsion systems and thrusters for satellites, launch
vehicles, and interceptors. Our products are utilized on various satellite and launch vehicle
programs such as Space Systems/Lorals 1300 series geostationary satellites.
Our European-based Aerospace Equipment operation designs, develops and manufactures high
performance valves, pressure regulators, cold-gas propulsion systems, and precision structures for
space applications, especially in the European space market. These products are used on various
satellites and spacecraft, as well as on the Ariane 5 launch vehicle.
OTHER BUSINESSES. Our Other Businesses segment contains our water treatment equipment and real
estate activities. Our water treatment equipment business designs, manufactures and markets systems
for the control of noxious odors, the disinfection of water streams and the treatment of seawater.
Our real estate activities are not material.
- 24 -
Table of Contents
RESULTS OF OPERATIONS
REVENUES
December 31, | Increase | Percentage | ||||||||||||||
2009 | 2008 | (Decrease) | Change | |||||||||||||
Three Months Ended: |
||||||||||||||||
Fine Chemicals |
$ | 9,504 | $ | 20,384 | $ | (10,880 | ) | (53 | %) | |||||||
Specialty Chemicals |
12,803 | 17,359 | (4,556 | ) | (26 | %) | ||||||||||
Aerospace Equipment |
8,325 | 5,756 | 2,569 | 45 | % | |||||||||||
Other Businesses |
3,432 | 2,130 | 1,302 | 61 | % | |||||||||||
Total Revenues |
$ | 34,064 | $ | 45,629 | $ | (11,565 | ) | (25 | %) | |||||||
Fine Chemicals. The decrease in Fine Chemicals segment revenues for the Fiscal 2010 first
quarter compared to the prior fiscal year first quarter is primarily due to the expected timing of
customer orders, and the resulting revenues, between our fiscal year quarterly periods. The
percentage of expected annual Fiscal 2010 Fine Chemicals segment revenues that occurred in our
Fiscal 2010 first quarter is substantially less than the percentage of annual Fiscal 2009 revenues
that occurred in our Fiscal 2009 first quarter. As a secondary factor, we expect Fiscal 2010
annual revenues to decline as compared to Fiscal 2009 due to reduced orders for core products. A
portion of this decline occurred in the Fiscal 2010 first quarter.
Specialty Chemicals. Specialty Chemicals segment revenues include the operating results from our
perchlorate, sodium azide and Halotron product lines, with perchlorates comprising 86% and 92% of
Specialty Chemicals segment revenues in the Fiscal 2010 and Fiscal 2009 first quarters,
respectively. The variances in Specialty Chemicals segment revenues reflect the following factors:
| A 46% decrease in perchlorate volume offset by a 27% increase in the related average price per pound. | |
| Sodium azide revenues increased $729 for the Fiscal 2010 first quarter, reflecting increased sales outside the U.S. | |
| Halotron revenues were consistent between the first quarter periods. |
The decrease in volume for the Fiscal 2010 first quarter is consistent with our expectation that
total perchlorate volume for Fiscal 2010 is anticipated to decline by approximately 50% compared to
the prior fiscal year. We also expect that the average price per pound will increase
proportionately, and accordingly, we believe that Specialty Chemicals segment revenues will be down
slightly for Fiscal 2010 but within our range of our expectations for this non-growth segment. The
increase in average price per pound reflects price increases from our contractual Grade I AP
price-volume matrix offset by effects of increases in non-Grade I AP revenues. Space related
programs accounted for the most significant component of Grade I AP revenues for both the Fiscal
2010 and Fiscal 2009 first quarter. For the Fiscal 2010 first quarter, the greatest contributor to
revenue was the Ares program. For the Fiscal 2009 first quarter, the greatest contributor to
segment revenue was product for the Space Shuttle Reusable Solid Rocket Motor (RSRM) program.
Aerospace
Equipment. For the Fiscal 2010 first quarter, Aerospace Equipment segment revenues increased $2,569 as
compared to the Fiscal 2009 first quarter representing growth from both the U.S. and European
operations of this segment. Growth for AMPAC ISPs U.S. operation was primarily due to
an increase in revenues from in-space propulsion engines, while AMPAC ISPs European
operations reported increases in revenues for both in-space propulsion engines and aerospace
structures.
- 25 -
Table of Contents
COST OF REVENUES AND GROSS MARGIN
December 31, | Increase | Percentage | ||||||||||||||
2009 | 2008 | (Decrease) | Change | |||||||||||||
Three Months Ended: |
||||||||||||||||
Revenues |
$ | 34,064 | $ | 45,629 | $ | (11,565 | ) | (25 | %) | |||||||
Cost of Revenues |
21,618 | 30,895 | (9,277 | ) | (30 | %) | ||||||||||
Gross Margin |
12,446 | 14,734 | (2,288 | ) | (16 | %) | ||||||||||
Gross Margin Percentage |
37 | % | 32 | % |
In addition to the factors detailed below, one of the most significant factors that affects,
and should continue to affect, the comparison of our consolidated gross margins from period to
period is the change in revenue mix between our segments.
For our Fiscal 2010 first quarter, cost of revenues was $21,618 compared to $30,895 for the prior
fiscal year first quarter. The consolidated gross margin percentage was 37% and 32% for our Fiscal
2010 and Fiscal 2009 first quarters, respectively. The following factors affected our Fiscal 2010
first quarter gross margin comparisons:
Fine Chemicals. Fine Chemicals segment gross margin percentage for the Fiscal 2010 first quarter
improved seventeen points compared to the prior fiscal year first quarter. The primary reason for
the improvement is that manufacturing inefficiencies that affected the first quarter of Fiscal 2009
did not reoccur in the Fiscal 2010 first quarter.
Specialty Chemicals. Specialty Chemicals segment gross margin percentage improved four points for
the Fiscal 2010 first quarter. For Fiscal 2010, we anticipate that both the price and
manufacturing cost of AP per pound will increase because of expected lower volume. However, in the
Fiscal 2010 first quarter, some of the perchlorates sold were manufactured in the prior year at a
lower unit cost. As such, when this prior year inventory was sold in the first quarter of Fiscal
2010, gross margins benefited.
Aerospace Equipment. Aerospace Equipment segment gross margin percentage declined thirteen points
in the Fiscal 2010 first quarter compared to the prior fiscal year first quarter. The decline in
gross margin is attributed to cost growth on certain systems contracts.
OPERATING EXPENSES
December 31, | Increase | Percentage | ||||||||||||||
2009 | 2008 | (Decrease) | Change | |||||||||||||
Three Months Ended: |
||||||||||||||||
Operating Expenses |
$ | 12,307 | $ | 11,309 | $ | 998 | 9 | % | ||||||||
Percentage of Revenues |
36 | % | 25 | % |
For our Fiscal 2010 first quarter, operating expenses increased $998 to $12,307 from $11,309
for the Fiscal 2009 first quarter. The most significant components of the net increase include:
| A decrease in Specialty Chemicals segment operating expenses primarily due to a decrease of $167 in employee related costs. | |
| An increase in Aerospace Equipment segment operating expenses of $595 primarily due to additional management and organization structure which was added to support this segments European growth strategy. | |
| An increase in corporate expenses, the largest component of which is an increase of $215 in non-cash, stock-based compensation. | |
| Fine Chemicals segment operating expenses were consistent between the Fiscal 2010 and Fiscal 2009 first quarters. |
- 26 -
Table of Contents
SEGMENT OPERATING INCOME (LOSS)
December 31, | Favorable | Percentage | ||||||||||||||
2009 | 2008 | (Unfavorable) | Change | |||||||||||||
Three Months Ended: |
||||||||||||||||
Fine Chemicals |
$ | (740 | ) | $ | (1,024 | ) | $ | 284 | 28 | % | ||||||
Specialty Chemicals |
5,831 | 7,606 | (1,775 | ) | (23 | %) | ||||||||||
Aerospace Equipment |
(362 | ) | 410 | (772 | ) | NM | ||||||||||
Other Businesses |
(17 | ) | 545 | (562 | ) | NM | ||||||||||
Segment Operating Income |
4,712 | 7,537 | (2,825 | ) | (37 | %) | ||||||||||
Corporate Expenses |
(4,573 | ) | (4,112 | ) | (461 | ) | 11 | % | ||||||||
Operating Income (Loss) |
$ | 139 | $ | 3,425 | $ | (3,286 | ) | (96 | %) | |||||||
NM=Not meaningful. |
Segment operating income or loss includes all sales and expenses directly associated with each
segment. Environmental remediation charges, corporate general and administrative costs and interest
are not allocated to segment operating results. Fluctuations in segment operating income or loss
are driven by changes in segment revenues, gross margins and operating expenses, each of which is
discussed in greater detail above.
BACKLOG
Agreements with our Fine Chemicals segment customers typically include multi-year supply
agreements. These agreements may contain provisional order volumes, minimum order quantities,
take-or-pay provisions, termination fees and other customary terms and conditions, which we do not
include in our computation of backlog. Fine Chemicals segment backlog includes unfulfilled firm
purchase orders received from a customer, including both purchase orders which are issued against a
related supply agreement and stand-alone purchase orders. Fine Chemicals segment backlog was
$79,300 and $28,200 as of December 31, 2009 and September 30, 2009, respectively. We anticipate
order backlog as of December 31, 2009 to be substantially filled during the next twelve months.
Our Aerospace Equipment segment is a government contractor, and accordingly, total backlog includes
both funded backlog (contracts, or portions of contracts, for which funding is contractually
obligated by the customer) and unfunded backlog (contracts, or portions of contracts, for which
funding is not currently contractually obligated by the customer). We compute Aerospace Equipment
segment total and funded backlog as the total contract value less revenues that have been
recognized under the percentage-of-completion method of accounting. Aerospace Equipment segment
total backlog and funded backlog were approximately $46,500 and $37,000, respectively, as of
December 31, 2009, compared to total backlog and funded backlog of $46,800 and $38,900,
respectively, as of September 30, 2009. We anticipate funded backlog as of December 31, 2009 to be
substantially completed during the next twelve months.
Backlog is not a meaningful measure for our other business lines.
- 27 -
Table of Contents
LIQUIDITY AND CAPITAL RESOURCES
CASH FLOWS
Three Months Ended December 31, | Percentage | |||||||||||||||
2009 | 2008 | Change | Change | |||||||||||||
Cash Provided (Used) By: |
||||||||||||||||
Operating activities |
$ | 18,107 | $ | 6,950 | $ | 11,157 | 161 | % | ||||||||
Investing activities |
(1,099 | ) | (8,462 | ) | 7,363 | (87 | %) | |||||||||
Financing activities |
(59 | ) | (73 | ) | 14 | (19 | %) | |||||||||
Effect of changes in exchange rates on cash |
(11 | ) | | (11 | ) | NM | ||||||||||
Net change in cash for period |
$ | 16,938 | $ | (1,585 | ) | $ | 18,523 | NM | ||||||||
NM = Not meanginful. |
Operating Activities. Operating activities provided cash of $18,107 for the Fiscal 2010
three-month period compared to $6,950 for the prior fiscal year three-month period, resulting in an
increase of $11,157 from the prior fiscal year three-month period.
Significant components of the change in cash flow from operating activities include:
| A decrease in cash due to less profit from our operations of $3,057. | |
| An increase in cash provided by working capital accounts of $13,653, excluding the effects of interest and income taxes. | |
| An increase in cash taxes refunded of $807. | |
| An increase in cash paid for interest of $31. | |
| An increase in cash used for environmental remediation of $315. | |
| Other increases in cash provided by operating activities of $100. |
The increase in cash provided by working capital accounts for the Fiscal 2010 first quarter is
primarily due to a decrease in accounts receivable balances for our Specialty Chemicals segment
from its higher balance at September 30, 2009, which were substantially collected in October 2009.
We consider these working capital changes to be routine and within the normal production cycle of
our products. The production of most fine chemical products requires a length of time that exceeds
one quarter. In addition, the timing of Aerospace Equipment segment revenues recognized under the
percentage-of-completion method differs from the timing of the related billings to customers. Therefore, in any given quarter, accounts receivable, work-in-progress inventory or deferred
revenues can increase or decrease significantly. We expect that our working capital may vary
normally by as much as $10,000 from quarter to quarter.
Investing Activities. Capital expenditures decreased by $710 in the Fiscal 2010 first quarter
compared to the prior fiscal year first quarter due to the timing of expenditures. Capital
expenditures in both periods are primarily maintenance capital related.
We are anticipating our capital expenditures, which do not include environmental remediation
spending, for Fiscal 2010 to range from approximately $10,000 to approximately $14,000 million.
Amounts above the lower end of the range represent discretionary growth capital spending.
LIQUIDITY AND CAPITAL RESOURCES. As of December 31, 2009, we had cash of $38,619. Our primary
source of working capital is cash flows from operations. In addition, we have available funds
under our committed revolving credit line, which matures in February 2012. Our revolving line of
credit had availability of $18,107 as of December 31, 2009. Availability is computed as the total
commitment of $20,000 less outstanding borrowings and outstanding letters of credit, if any. We
believe that changes in cash flow from operations during our Fiscal 2010 first quarter reflect
short-term timing and as such do not represent significant changes in our sources and uses of cash.
Because our revenues, and related
- 28 -
Table of Contents
customer invoices and collections, are characterized by relatively few individually
significant transactions, our working capital balances can vary normally by as much as $10,000 from
period to period.
We may incur additional debt to fund capital projects, strategic initiatives or for other general
corporate purposes, subject to our existing leverage, the value of our unencumbered assets and
borrowing limitations imposed by our lenders. The availability of our cash inflows is affected by
the timing, pricing and magnitude of orders for our products. From time to time, we may explore
options to refinance our borrowings.
The timing of our cash outflows is affected by payments and expenses related to the manufacture of
our products, capital projects, pension funding, interest on our debt obligations and environmental
remediation or other contingencies, which may place demands on our short-term liquidity. Although
we are not currently party to any material pending legal proceedings, we are from time to time
subject to claims and lawsuits related to our business operations and we have incurred legal and
other costs as a result of litigation and other contingencies. We may incur material legal and
other costs associated with the resolution of litigation and contingencies in future periods, and,
to the extent not covered by insurance, they may adversely affect our liquidity.
In contemplating the adequacy of our liquidity and available capital, we consider factors such as:
| current results of operations, cash flows and backlog; | |
| anticipated changes in operating trends, including anticipated changes in revenues and margins; | |
| cash requirements related to our debt agreements and pension plans; and | |
| cash requirements related to our remediation activities, including amounts that we expect to spend through fall 2011 for the engineering, design, installation and cost of additional remediation equipment (Remediation Capital). See further discussion under the heading Environmental Remediation AMPAC Henderson Site below. |
We do not currently anticipate that the factors noted above will have material affects on our
ability to meet our future liquidity requirements. We anticipate funding Remediation Capital with
cash on hand. We continue to believe that our cash flows from operations, existing cash balances
and existing or future debt arrangements will be adequate for the foreseeable future to satisfy the
needs of our operations on both a short-term and long-term basis. Further, accounting charges for
environmental remediation and cash spent for Remediation Capital do not impact our bank covenant
compliance charges.
LONG TERM DEBT AND REVOLVING CREDIT FACILITIES
Senior Notes. In February 2007, we issued and sold $110,000 aggregate principal amount of 9.0%
Senior Notes due February 1, 2015 (collectively, with the exchange notes issued in August 2007 as
referenced below, the Senior Notes). Proceeds from the issuance of the Senior Notes were used to
repay our former credit facilities. The Senior Notes accrue interest at an annual rate of 9.0%,
payable semi-annually in February and August. The Senior Notes are guaranteed on a senior
unsecured basis by all of our existing and future material U.S. subsidiaries. The Senior Notes are:
| ranked equally in right of payment with all of our existing and future senior indebtedness; | |
| ranked senior in right of payment to all of our existing and future senior subordinated and subordinated indebtedness; | |
| effectively junior to our existing and future secured debt to the extent of the value of the assets securing such debt; and | |
| structurally subordinated to all of the existing and future liabilities (including trade payables) of each of our subsidiaries that do not guarantee the Senior Notes. |
- 29 -
Table of Contents
The Senior Notes may be redeemed by us, in whole or in part, under the following circumstances:
| at any time prior to February 1, 2011 at a price equal to 100% of the purchase amount of the Senior Notes plus an applicable premium as defined in the related indenture; | |
| at any time on or after February 1, 2011 at redemption prices beginning at 104.5% of the principal amount to be redeemed and reducing to 100% by February 1, 2013; | |
| until February 1, 2010, up to 35% of the principal amount of the Senior Notes at a redemption price of 109% of the principal amount thereof, plus accrued and unpaid interest thereon, with the proceeds of certain sales of our equity securities; and | |
| under certain changes of control, we must offer to purchase the Senior Notes at 101% of their aggregate principal amount, plus accrued interest. |
The Senior Notes were issued pursuant to an indenture which contains certain customary events of
default, including cross default provisions if we default under our existing and future debt
agreements having, individually or in the aggregate, a principal or similar amount outstanding of
at least $10,000, and certain other covenants limiting, subject to exceptions, carve-outs and
qualifications, our ability to:
| incur additional debt; | |
| pay dividends or make other restricted payments; | |
| create liens on assets to secure debt; | |
| incur dividend or other payment restrictions with regard to restricted subsidiaries; | |
| transfer or sell assets; | |
| enter into transactions with affiliates; | |
| enter into sale and leaseback transactions; | |
| create an unrestricted subsidiary; | |
| enter into certain business activities; or | |
| effect a consolidation, merger or sale of all or substantially all of our assets. |
In connection with the closing of the sale of the Senior Notes, we entered into a registration
rights agreement which required us to file a registration statement to offer to exchange the Senior
Notes for notes that have substantially identical terms as the Senior Notes and are registered
under the Securities Act of 1933, as amended. In July 2007, we filed a registration statement with
the SEC with respect to an offer to exchange the Senior Notes as required by the registration
rights agreement, which registration statement was declared effective by the SEC. In August 2007,
we completed the exchange of 100% of the Senior Notes for substantially identical notes which are
registered under the Securities Act of 1933, as amended.
Revolving Credit Facility. In February 2007, we entered into an Amended and Restated Credit
Agreement, as amended as of July 7, 2009 (the Revolving Credit Facility), with Wachovia Bank,
National Association, and certain other lenders, which provides a secured revolving credit facility
in an aggregate principal amount of up to $20,000 with an initial maturity of 5 years. We may
prepay and terminate the Revolving Credit Facility at any time. The annual interest rates
applicable to loans under the Revolving Credit Facility are, at our option, either the Alternate
Base Rate or LIBOR Rate (each as defined in the Revolving Credit Facility) plus, in each case, an
applicable margin. The applicable margin is tied to our total leverage ratio (as defined in the
Revolving Credit Facility). In addition, we pay commitment fees, other fees related to the
issuance and maintenance of letters of credit, and certain agency fees.
The Revolving Credit Facility is guaranteed by and secured by substantially all of the assets of
our current and future domestic subsidiaries, subject to certain exceptions as set forth in the
Revolving Credit Facility. The Revolving Credit Facility contains certain negative covenants
restricting and limiting our ability to, among other things:
| incur debt, incur contingent obligations and issue certain types of preferred stock; | |
| create liens; |
- 30 -
Table of Contents
| pay dividends, distributions or make other specified restricted payments; | |
| make certain investments and acquisitions; | |
| enter into certain transactions with affiliates; | |
| enter into sale and leaseback transactions; and | |
| merge or consolidate with any other entity or sell, assign, transfer, lease, convey or otherwise dispose of assets. |
Financial covenants under the Revolving Credit Facility include quarterly requirements for total
leverage ratio of less than or equal to 5.25 to 1.00 (Total Leverage Ratio), and interest
coverage ratio of at least 2.50 to 1.00 (Interest Coverage Ratio). The Revolving Credit Facility
defines Total Leverage Ratio as the ratio of Consolidated Funded Debt to Consolidated EBITDA and
Interest Coverage Ratio as the ratio of Consolidated EBITDA to Consolidated Interest Expense. With
respect to these covenant compliance calculations, Consolidated EBITDA, as defined in the Revolving Credit Facility (hereinafter,
referred to as Credit Facility EBITDA), differs from typical EBITDA calculations and our
calculation of Adjusted EBITDA, which is used in certain of our public releases and in connection
with our incentive compensation plan. The most significant difference in the Credit Facility
EBITDA calculation is the inclusion of cash payments for environmental remediation as part of the
calculation. The following statements summarize the elements of those definitions that are material
to our computations. Consolidated Funded Debt generally includes principal amounts outstanding
under our Senior Notes, Revolving Credit Facility, capital leases and notional amounts for
outstanding letters of credit. Credit Facility EBITDA is generally computed as consolidated net
income (loss) plus income tax expense (benefit), interest expense, depreciation and amortization,
and stock-based compensation expense and less cash payments for environmental remediation and other
non-recurring gains in excess of $50. In accordance with the definitions contained in the Revolving
Credit Facility, as of December 31, 2009, our Total Leverage Ratio was 3.86 to 1.00 and our
Interest Coverage Ratio was 2.88 to 1.00.
The Revolving Credit Facility also contains usual and customary events of default (subject to
certain threshold amounts and grace periods), including cross-default provisions that include our
Senior Notes. If an event of default occurs and is continuing, we may be required to repay the
obligations under the Revolving Credit Facility prior to its stated maturity and the related
commitments may be terminated. We do not believe that it is reasonably likely, in the near or
long-term, that we will be in violation of our debt covenants.
As of December 31, 2009, under our Revolving Credit Facility, we had no borrowings outstanding,
availability of $18,107, and we were in compliance with its various financial covenants.
Availability is computed as the total commitment of $20,000 less outstanding borrowings and
outstanding letters of credit, if any.
PENSION BENEFITS. We maintain three defined benefit pension plans which cover substantially all of
our U.S. employees, excluding employees of our Aerospace Equipment segment: the Amended and
Restated American Pacific Corporation Defined Benefit Pension Plan, the Ampac Fine Chemicals LLC
Pension Plan for Salaried Employees (the AFC Salaried Plan), and the Ampac Fine Chemicals LLC
Pension Plan for Bargaining Unit Employees (the AFC Bargaining Plan), each as amended and
restated. Collectively, these three plans are referred to as the Pension Plans. The AFC
Salaried Plan and the AFC Bargaining Plan were established in connection with our acquisition of
the AFC business in November 2005 and include the assumed liabilities for pension benefits to
existing employees at the acquisition date. Pension Plan benefits are paid based on an average of
earnings, retirement age, and length of service, among other factors.
Benefit obligations are measured annually as of September 30. As of September 30, 2009, the
Pension Plans had an unfunded benefit obligation of $21,221. For Fiscal 2009, we made
contributions to the Pension Plans in the amount of $2,941. We anticipate making minimum Pension
Plan contributions in the amount of $2,568 during Fiscal 2010. We are required to make minimum
contributions to our Pension Plans pursuant to the minimum funding requirements of the Internal
Revenue Code of 1986, as amended, and the Employee Retirement Income Security Act of 1974, as
amended. In accordance with federal requirements, our minimum funding obligations are determined
annually based on a measurement date of
- 31 -
Table of Contents
October 1. The fair value of Pension Plan assets is a key
factor in determining our minimum funding obligations. Holding all other variables constant, a 10%
decline in asset value as of September 30, 2009 would increase our minimum funding obligations for
Fiscal 2010 by approximately $500.
In addition, we maintain the American Pacific Corporation Supplemental Executive Retirement Plan,
as amended and restated (the SERP) that, as of December 31, 2009, included five participants
comprised of active and former executive officers. The SERP is an unfunded plan and as of September
30, 2009, the SERP obligation was $6,981. For Fiscal 2009, we paid retirement benefits of $127.
We anticipate paying retirement benefits in the amount of $482 during Fiscal 2010. Payments for
retirement benefits should increase in future years when each of the three current active
participants retires. The future increase in retirement benefits will be determined based on
certain variables including each participating individuals actual retirement date, rate of
compensation and years of service.
During Fiscal 2009, our aggregate Pension Plans and SERP liability increased significantly
primarily due to changes in actuarial assumption such as the discount rate. The change was
recorded as an increase in Pension Obligations and a corresponding decrease in Shareholders Equity
(Accumulated Other Comprehensive Loss). The increase in Pension Obligation is not anticipated to
cause a material change in our Fiscal 2010 funding requirements.
ENVIRONMENTAL REMEDIATION AMPAC HENDERSON SITE. We accrue for anticipated costs associated with
environmental remediation that are probable and estimable. On a quarterly basis, we review our
estimates of future costs that could be incurred for remediation activities. In some cases, only a
range of reasonably possible costs can be estimated. In establishing our reserves, the most
probable estimate is used; otherwise, we accrue the minimum amount of the range.
During the third quarter of our fiscal year ended September 30, 2005, we recorded a charge for
$22,400 representing our estimate of the probable costs of our remediation efforts at our former
facility in Henderson, Nevada (the AMPAC Henderson Site), including the costs for capital
equipment, operating and maintenance (O&M), and consultants. The project consisted of two
primary phases: the initial construction of the remediation equipment phase and the O&M phase.
During the fiscal year ended September 30, 2006, we increased our total cost estimate of probable
costs for the construction phase by $3,600 due primarily to changes in the engineering designs,
delays in receiving permits and the resulting extension of construction time.
In-situ
bioremediation (ISB) is a new technology on the scale being used at the AMPAC Henderson Site. Accordingly, as we
gain ISB operational experience, we have been and are observing certain conditions, operating
results and other data which we consider in updating the assumptions used to determine our cost
estimates. The two most significant assumptions are the estimated speed of groundwater flowing to
our remediation extraction wells and the estimated annual O&M costs.
Late in Fiscal 2009, we gained additional information from groundwater modeling that indicates
groundwater emanating from the AMPAC Henderson Site in certain areas in deeper zones (more than 150
feet below ground surface) is moving toward our existing remediation facility at a much slower pace
than previously estimated. Utilization of our existing facilities alone, at this lower groundwater
pace, could, according to this recently created groundwater model, extend the life of our
remediation project to well in excess of fifty years. As a result of this additional data, we
re-evaluated our remediation operations. This evaluation indicates that we should be able to
significantly reduce the total project time, and ultimately the total cost of the project, by
installing additional groundwater extraction wells in the deeper, more concentrated areas, thereby
providing for a more aggressive remediation treatment. The additional wells and related
remediation equipment will incorporate above ground treatment to supplement or possibly replace by
consolidation our existing ISB process. With the additional extraction wells and equipment, we
estimate that the total remaining project life for the existing and new, more aggressive deep zone
systems could range from 10 to 29 years, beginning with Fiscal 2010. Within that range, we
estimate that a range of 13 to 23 years is more likely. Groundwater speed, perchlorate
concentrations, aquifer characteristics and forecasted groundwater extraction rates continue to be
key variables underlying our estimate of the
- 32 -
Table of Contents
life of the project. If additional information
becomes available in the future that is different than information currently available to us, our
estimate of the resulting project life could change significantly.
In our Fiscal 2009 fourth quarter, we accrued approximately $9,600 representing our estimate of the
cost to engineer, design, and install this additional equipment. We anticipate that these amounts
will be spent through and the new equipment operational in
approximately fall 2011. However, because we are in
the early design and engineering steps, this estimate involves a number of significant assumptions.
Due to uncertainties inherent in making early stage estimates, our estimate may later require
significant revision as new facts become available and circumstances change.
In addition to accruing approximately $9,600 for engineering, design, installation and cost of
additional equipment, in our Fiscal 2009 fourth quarter, we increased our estimate of total
remaining O&M costs by $4,100 due primarily to incremental O&M costs to operate and maintain the
additional equipment once installed. Total O&M expenses are currently estimated at approximately $1,000 per year and
estimated to increase to approximately $1,300 per year after the additional equipment becomes
operational. To estimate O&M costs, we consider, among other factors, the project scope and
historical expense rates to develop assumptions regarding labor, utilities, repairs, maintenance
supplies and professional service costs. If additional information becomes available in the future
that is different than information currently available to us and thereby lead us to different
conclusions, our estimate of O&M expenses could change significantly.
In addition, certain remediation activities are conducted on public lands under operating permits.
In general, these permits require us to return the land to its original condition at the end of the
permit period. Estimated costs associated with removal of remediation equipment from the land are
not material and are included in our range of estimated costs.
As of December 31, 2009, the aggregate range of anticipated environmental remediation costs was
from approximately $22,300 to approximately $46,500 based on a possible total remaining life of the
project ranging from 10 to 29 years. The accrued amount was $26,008, based on 13 years (beginning
with Fiscal 2010), or the low end of the more likely range of 13 to 23 years as no amount within
the range was more likely. These estimates are based on information currently available to us and
may be subject to material adjustment upward or downward in future periods as new facts or
circumstances may indicate.
CONTRACTUAL OBLIGATIONS. Our contractual obligations are summarized in our Annual Report on Form
10-K for Fiscal 2009. We have contractual obligations related to our Senior Notes, interest on
Senior Notes, capital leases, interest on capital leases, and operating leases. As of December 31,
2009, there have been no material changes to our contractual obligations from September 30, 2009.
In addition, at December 31, 2009:
| We have recorded an estimated liability for environmental remediation of $26,608 (see Note 7 to the condensed consolidated financial statements included in Item 1 of this report). We expect to spend approximately $2,522 for environmental remediation during Fiscal 2010. | |
| We have recorded aggregate unfunded Pension Plans and SERP obligations of $29,055 (see Note 10 to the condensed consolidated financial statements included in Item 1 of this report). We expect to contribute $3,050 to our Pension Plans and SERP during Fiscal 2010. | |
| We have uncertain tax positions totaling $652. We are unable to reasonably estimate the timing of the related payments, if any. | |
| We also maintain the Revolving Credit Facility, which provides revolving credit in an aggregate principal amount of up to $20,000 with an initial maturity in February 2012. At December 31, 2009, we had no balance outstanding under the Revolving Credit Facility. We may prepay and terminate the Revolving Credit Facility at any time. |
- 33 -
Table of Contents
OFF-BALANCE SHEET ARRANGEMENTS
Letters of Credit. As of December 31, 2009, we had $1,893 in outstanding standby letters of credit
which mature through July 2013. These letters of credit principally secure performance of certain
water treatment equipment sold by us and payment of fees associated with the delivery of natural
gas and power.
Employee Agreements. We have an employment agreement with our Chief Executive Officer. The term of
the employment agreement currently ends on September 30, 2012, unless amended or extended in
accordance with the terms of the agreement or otherwise. Significant contract provisions include
annual base salary, health care benefits, and non-compete provisions. The employment agreement is
primarily an at will employment agreement, under which we may terminate the executive officers
employment for any or no reason. Generally, the agreement provides that a termination without
cause obligates us to pay certain severance benefits specified in the contract.
Effective as of July 8, 2008, we entered into severance agreements with each of our Vice President,
Administration and our Chief Financial Officer, which, generally, provide that a termination of the
executive without cause obligates us to pay certain severance benefits specified in the contract.
In addition, certain other key divisional executives are eligible for severance benefits.
Estimated minimum aggregate severance benefits under all of these agreements and arrangements was
$4,200 as of December 31, 2009.
CRITICAL ACCOUNTING POLICIES
The preparation of financial statements in conformity with generally accepted accounting
principles in the United States of America requires that we adopt accounting policies and make
estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of
contingent assets and liabilities and the reported amounts of revenue and expenses.
Application of the critical accounting policies discussed below requires significant judgment,
often as the result of the need to make estimates of matters that are inherently uncertain. If
actual results were to differ materially from the estimates made, the reported results could be
materially affected. However, we are not currently aware of any reasonably likely events or
circumstances that would result in materially different results.
SALES AND REVENUE RECOGNITION. Revenues from our Specialty Chemicals segment, Fine Chemicals
segment, and Other Businesses segment are recognized when persuasive evidence of an arrangement
exists, delivery has occurred or services have been rendered, title passes, the price is fixed or
determinable and collectability is reasonably assured. Almost all products sold by our Fine
Chemicals segment are subject to customer acceptance periods. Specifically, these customers have
contractually negotiated acceptance periods from the time they receive certificates of analysis and
compliance (Certificates) to reject the material based on issues with the quality of the product,
as defined in the applicable agreement. At times we receive payment in advance of customer
acceptance. If we receive payment in advance of customer acceptance, we record deferred revenues
and deferred costs of revenue upon delivery of the product and recognize revenues in the period
when the acceptance period lapses or the customers acceptance has occurred.
Some of our perchlorate and fine chemicals products customers have requested that we store
materials purchased from us in our facilities (Bill and Hold transactions or arrangements). We
recognize revenue prior to shipment of these Bill and Hold transactions when we have satisfied the
criteria included in the relevant accounting standard, which include the point at which title and
risk of ownership transfer to our customers. These customers have specifically requested in
writing, pursuant to a contract, that we invoice for the finished product and hold the finished
product until a later date. For our Bill and Hold arrangements that contain customer acceptance
periods, we record deferred revenues and deferred costs of revenues when such products are
available for delivery and Certificates have been delivered to
- 34 -
Table of Contents
the customers. We recognize revenue
on our Bill and Hold transactions in the period when the acceptance period lapses or the customers
acceptance has occurred. The sales value of inventory, subject to Bill and Hold arrangements, at
our facilities was $21,786 and $25,882 as of December 31, 2009 and September 30, 2009,
respectively.
Revenues from our Aerospace Equipment segment are derived from contracts that are accounted for
using the percentage-of-completion method and measure progress on a cost-to-cost basis. Contract
revenues include change orders and claims when approved by the customer. The
percentage-of-completion method recognizes revenue as work on a contract progresses. Revenues are
calculated based on the percentage of total costs incurred in relation to total estimated costs at
completion of the contract. For fixed-price and fixed-price-incentive contracts, if at any time
expected costs exceed the value of the contract, the loss is recognized immediately. We do not
incur material pre-contract costs.
DEPRECIABLE OR AMORTIZABLE LIVES OF LONG-LIVED ASSETS. Our depreciable or amortizable long-lived
assets include property, plant and equipment and intangible assets,
which are recorded at cost. Depreciation or amortization is recorded using the straight-line method over the shorter of the
assets estimated economic useful life or the lease term, if the asset is subject to a capital
lease. Economic useful life is the duration of time that we expect the asset to be productively
employed by us, which may be less than its physical life. Significant assumptions that affect the
determination of estimated economic useful life include: wear and tear, obsolescence, technical
standards, contract life, and changes in market demand for products.
The estimated economic useful life of an asset is monitored to determine its appropriateness,
especially in light of changed business circumstances. For example, changes in technological
advances, changes in the estimated future demand for products, or excessive wear and tear may
result in a shorter estimated useful life than originally anticipated. In these cases, we would
depreciate the remaining net book value over the new estimated remaining life, thereby increasing
depreciation expense per year on a prospective basis. Likewise, if the estimated useful life is
increased, the adjustment to the useful life decreases depreciation expense per year on a
prospective basis.
IMPAIRMENT OF LONG-LIVED ASSETS. We test our property, plant and equipment and amortizable
intangible assets for recoverability when events or changes in circumstances indicate that their
carrying amounts may not be recoverable. Examples of such circumstances include, but are not
limited to, operating or cash flow losses from the use of such assets or changes in our intended
uses of such assets. To test for recovery, we group assets (an Asset Group) in a manner that
represents the lowest level for which identifiable cash flows are largely independent of the cash
flows of other groups of assets and liabilities. Our Asset Groups are typically identified by
facility because each facility has a unique cost overhead and general and administrative expense
structure that is supported by cash flows from products produced at the facility. The carrying
amount of an Asset Group is not recoverable if it exceeds the sum of the undiscounted cash flows
expected to result from the use and eventual disposition of the Asset Group.
If we determine that an Asset Group is not recoverable, then we would record an impairment charge
if the carrying value of the Asset Group exceeds its fair value. Fair value is based on estimated
discounted future cash flows expected to be generated by the Asset Group. The assumptions
underlying cash flow projections would represent managements best estimates at the time of the
impairment review. Some of the factors that management would consider or estimate include: industry
and market conditions, sales volume and prices, costs to produce and inflation. Changes in key
assumptions or actual conditions which differ from estimates could result in an impairment charge.
We would use reasonable and supportable assumptions when performing impairment reviews but cannot
predict the occurrence of future events and circumstances that could result in impairment charges.
- 35 -
Table of Contents
When we review Asset Groups for recoverability, we also consider depreciation estimates and methods
or the amortization period, in each case as required by applicable accounting standards. Any
revision to the remaining useful life of a long-lived asset resulting from that review also is
considered in developing estimates of future cash flows used to test the Asset Group for
recoverability.
GOODWILL. Goodwill is not amortized. We test goodwill for impairment at the reporting unit level
on an annual basis, as of September 30, or more frequently if an event occurs or circumstances
change that indicate that the fair value of a reporting unit could be below its carrying amount.
The impairment test consists of comparing the fair value of a reporting unit with its carrying
amount including goodwill, and, if the carrying amount of the reporting unit exceeds its fair
value, comparing the implied fair value of goodwill with its carrying amount. An impairment loss
would be recognized for the carrying amount of goodwill in excess of its implied fair value.
ENVIRONMENTAL COSTS. We are subject to environmental regulations that relate to our past and
current operations. We record liabilities for environmental remediation costs when our assessments
indicate that remediation efforts are probable and the costs can be reasonably estimated. On a
quarterly basis, we review our estimates of future costs that could be incurred for remediation
activities. In some cases, only a range of reasonably possible costs can be estimated. In
establishing our reserves, the most probable estimate is used; otherwise, we accrue the minimum
amount of the range. Estimates of liabilities are based on currently available facts, existing technologies and presently enacted
laws and regulations. These estimates are subject to revision in future periods based on actual
costs or new circumstances. Accrued environmental remediation costs include the undiscounted cost
of equipment, operating and maintenance costs, and fees to outside law firms and consultants, for
the estimated duration of the remediation activity. Estimating environmental cost requires us to
exercise substantial judgment regarding the cost, effectiveness and duration of our remediation
activities. Actual future expenditures could differ materially from our current estimates.
We evaluate potential claims for recoveries from other parties separately from our estimated
liabilities. We record an asset for expected recoveries when recoveries of the amounts are
probable.
INCOME TAXES. We account for income taxes under the asset and liability method. Deferred tax assets
and liabilities are recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of assets and liabilities and their respective tax basis.
Deferred tax assets and liabilities are measured, separately for each tax-paying entity in each tax
jurisdiction, using enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled. The effect on deferred tax
assets and liabilities of a change in tax rates is recognized in the period that includes the
enactment date.
When measuring deferred tax assets, we assess whether a valuation allowance should be established.
A valuation allowance is established if, based on the weight of available evidence, it is more
likely than not that some portion or all of the deferred tax assets will not be realized. The
assessment of valuation allowance requirements, if any, involves significant estimates regarding
the timing and amount of reversal of taxable temporary differences, future taxable income and the
implementation of tax planning strategies. We rely on deferred tax liabilities in our assessment
of the realizability of deferred tax assets if the temporary timing difference is anticipated to
reverse in the same period and jurisdiction and are of the same character as the temporary
differences giving rise to the deferred tax assets. We weigh both positive and negative evidence in
determining whether it is more likely than not that a valuation allowance is required.
As of September 30, 2009, recovery of our U.S. jurisdiction deferred tax assets, net of applicable
deferred tax liabilities, required that we generate approximately $68,000 in taxable income in
periods ranging from one to at least 13 years in the future. To determine whether a valuation
allowance is required, we project our future taxable income. The projections require us to make
assumptions regarding our product revenues, gross margins and operating expenses.
- 36 -
Table of Contents
For our U.S. tax jurisdictions, the most significant positive evidence is our historical long-term
trend of profitable operations and our forecast that such trend will continue in future periods
when temporary differences are anticipated to reverse. Positive evidence also includes the lack of
reliance on success in implementing tax planning strategies, utilization of short carry-back
periods or appreciated asset values. Further, we do not have a history of tax credits expiring
unused. For foreign tax jurisdictions, the most compelling negative evidence is a history of
unprofitable operations. Accordingly, we have fully reserved our foreign deferred tax assets.
We account for uncertain tax positions in accordance with an accounting standard which creates a
single model to address uncertainty in income tax positions and prescribes the minimum recognition
threshold a tax position is required to meet before being recognized in the financial statements.
The standard also provides guidance on derecognition, measurement, classification, interest and
penalties, accounting in interim periods, disclosure and transition.
Under this standard, we may recognize tax benefits from an uncertain position only if it is more
likely than not that the position will be sustained upon examination by taxing authorities based on
the technical merits of the issue. The amount recognized is the largest benefit that we believe has
greater than a 50% likelihood of being realized upon settlement. Actual income taxes paid may vary
from estimates depending upon changes in income tax laws, actual results of operations, and the
final audit of tax returns by taxing authorities. Tax assessments may arise several years after tax
returns have been filed.
PENSION BENEFITS. We sponsor four defined benefit pension plans in various forms for employees who
meet eligibility requirements. Applicable accounting standards require that we make assumptions
and use statistical variables in actuarial models to calculate our pension obligations and the
related periodic pension expense. The most significant assumptions are the discount rate and the
expected rate of return on plan assets. Additional assumptions include the future rate of
compensation increases, which is based on historical plan data and assumptions on demographic
factors such as retirement, mortality and turnover. Depending on the assumptions selected, pension
expense could vary significantly and could have a material effect on reported earnings. The
assumptions used can also materially affect the measurement of benefit obligations.
The discount rate is used to estimate the present value of projected future pension payments to all
participants. The discount rate is generally based on the yield on AAA/AA-rated corporate
long-term bonds. At September 30 of each year, the discount rate is determined using bond yield
curve models matched with the timing of expected retirement plan payments. Our discount rate
assumption was 6.40 percent as of September 30, 2009. Holding all other assumptions constant, a
hypothetical increase or decrease of 25 basis points in the discount rate assumption would
increase or decrease annual pension expense by approximately $300.
The expected long-term rate of return on plan assets represents the average rate of earnings
expected on the plan funds invested in a specific target asset allocation. The expected long-term
rate of return assumption on pension plan assets was 8.00 percent in Fiscal 2009. Holding all other
assumptions constant, a hypothetical 25 basis point increase or decrease in the assumed long-term
rate of return would increase or decrease annual pension expense by approximately $100.
RECENTLY ISSUED OR ADOPTED ACCOUNTING STANDARDS. In September 2006, the Financial Accounting
Standards Board (the FASB) issued a new standard which defines fair value, establishes a
framework for measuring fair value in generally accepted accounting principles in the United States
of America, and expands disclosures about fair value measurements. In February 2008, the FASB
deferred this standard for one year as it applied to certain items, including assets and
liabilities initially measured at fair value in a business combination, reporting units and certain
assets and liabilities measured at fair value in connection with goodwill impairment tests, and
long-lived assets measured at fair value for impairment assessments. The standard applies under
other accounting pronouncements that require or permit fair value measurements, the FASB having
previously concluded in those accounting pronouncements that fair value is the relevant measurement
attribute. This standard was effective for us on October 1, 2008; however, we did not adopt all the
provisions of the standard as the FASB delayed
- 37 -
Table of Contents
the effective date of its application to
non-financial assets and liabilities. The remaining provisions became effective for us beginning
October 1, 2009. The adoption of this standard did not have a material impact on our results of
operations, financial position or cash flows.
In December 2007, the FASB issued a new standard that significantly changed the accounting for
business combinations. Under the standard, an acquiring entity is required to recognize all the
assets acquired and liabilities assumed in a transaction at the acquisition-date fair value with
limited exceptions. The standard also includes a substantial number of new disclosure
requirements. The standard applies to us for business combinations with acquisition dates on or
after October 1, 2009. We expect that the new standard will have an impact on our accounting for
future business combinations, but the effect is dependent upon acquisitions at that time.
In December 2007, the FASB issued a new standard that establishes revised accounting and reporting
standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a
subsidiary. Specifically, the standard requires the recognition of a noncontrolling interest
(minority interest) as equity in the consolidated financial statements and separate from the
parents equity. The amount of net income attributable to the noncontrolling interest will be
included in consolidated net income on the face of the income statement. It also clarifies that
changes in a parents ownership interest in a subsidiary that do not result in deconsolidation are
equity transactions if the parent retains its controlling financial interest. The standard requires
that a parent recognize a gain or loss in net income when a
subsidiary is deconsolidated. Such gain or loss will be measured using the fair value of the noncontrolling
equity investment on the deconsolidation date. The standard also includes expanded disclosure
requirements regarding the interests of the parent and its noncontrolling interest. The standard
was effective for us beginning on October 1, 2009. We currently have no entities or arrangements
that were affected by the adoption of this standard.
In April 2008, the FASB issued a new standard which amends the factors that should be considered in
developing renewal or extension assumptions used to determine the useful life of a recognized
intangible asset. The standard for determining the useful life of a recognized intangible asset
shall be applied prospectively to intangible assets acquired after the effective date. However, the
disclosure requirements must be applied prospectively to all intangible assets recognized in the
Companys financial statements as of the effective date. The standard was effective for us
beginning on October 1, 2009. The adoption of this standard did not have a material impact on our
results of operations, financial position or cash flows.
In December 2008, the FASB issued a new standard that provides guidance on an employers
disclosures about plan assets of a defined benefit pension or other postretirement plan. The
objectives of the disclosures include disclosure of investment allocation decisions, major
categories of plan assets, inputs and valuation techniques used to measure the fair value of plan
assets, the effect of certain fair value measurements, and significant concentrations of risk
within plan assets. The expanded disclosure requirements are effective for our fiscal year ending
September 30, 2010. The adoption of this standard is not expected to have a material impact on our
results of operations, financial position or cash flows.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK (Dollars in Thousands) Not
Applicable.
ITEM 4. CONTROLS AND PROCEDURES
The Companys management evaluated, with the participation of the Companys principal executive and
principal financial officers, the effectiveness of the Companys disclosure controls and procedures
(as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) to provide
reasonable assurance that information required to be disclosed by us in the reports that we file or
submit under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to
our management, including our principal executive and principal financial officers, as appropriate
to allow timely decisions regarding required disclosure, and is recorded, processed, summarized and
reported within the time periods specified in the SECs rules and forms. Based on their evaluation,
our principal executive and principal financial officers have concluded that our disclosure
controls and procedures
- 38 -
Table of Contents
were not effective as of December 31, 2009 due to a material weakness
relating to the Companys internal control over financial reporting, which we view as part of our
disclosure controls and procedures, as previously reported in Item 9A(T), Controls and
Procedures, within Managements Report on Internal Controls Over Financial Reporting contained
in the Companys Annual Report on Form 10-K for Fiscal 2009, as filed with the SEC on December
29, 2009. In particular, because the previously reported material weakness in internal control
over financial reporting, which was due to inadequate controls for non-routine transactions at the
Companys Fine Chemicals segment, had not been fully remediated as of the quarter ended December
31, 2009, our principal executive and principal financial officers concluded that our disclosure
controls and procedures were not effective as of December 31, 2009. Managements previously
reported material weakness determination was based upon the likelihood and potential magnitude of a
misstatement to the annual or interim financial statements being reasonably possible.
As a result of the identification of the previously reported material weakness in internal control
over financial reporting, corporate personnel performed additional analysis and procedures with
respect to the Fiscal 2010 first quarter in order to prepare the condensed consolidated financial
statements in accordance with generally accepted accounting principles in the United States of
America. These procedures were performed to test the propriety of Fine Chemicals segment revenue
recognition and included the following:
| Developed and implemented a comprehensive Fine Chemicals segment revenue recognition testing work program based on a risk assessment that determined the scope of transactions to be tested. | ||
| Reviewed significant manufacturing agreements, customer proposals and purchase orders, including contractual arrangements documented outside of the customers written contract or purchase order, related to revenues recorded in our Fiscal 2010 first quarter. |
As a result of the above described procedures, we recorded no additional corrections or adjustments
for the quarter ended December 31, 2009 in connection with the previously identified material
weakness.
During the quarter ended December 31, 2009, we undertook, and we continue to undertake, extensive
work to remedy the previously identified material weakness, including identifying specific
remediation initiatives. As of December 31, 2009, we identified and began to implement the
following actions:
| Improving the Fine Chemicals segment contract administration process to ensure the proper approval and circulation of all sales arrangements, including non-standard commitments; | ||
| Providing additional and on-going training to Fine Chemicals segment finance and accounting staff on the application of technical accounting pronouncements, especially in the area of revenue recognition. Additionally, we have begun to provide training to Fine Chemicals segment product managers and others involved in negotiating contractual arrangements with our customers to heighten the awareness of revenue recognition concepts, with emphasis on non-standard contracts; and | ||
| Establishing a process whereby corporate finance personnel provide a second review of the Fine Chemicals segments accounting treatment for significant sales arrangements. |
There were no changes in our internal control over financial reporting that occurred during our
last fiscal quarter that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting, other than those activities described above.
- 39 -
Table of Contents
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Although we are not currently party to any material pending legal proceedings, we are from time to
time subject to claims and lawsuits related to our business operations. Any such claims and
lawsuits could be costly and time consuming and could divert our management and key personnel from
our business operations. In connection with any such claims and lawsuits, we may be subject to
significant damages or equitable remedies relating to the operation of our business. Any such
claims and lawsuits may materially harm our business, results of operations and financial
condition.
ITEM 1A. RISK FACTORS (Dollars in Thousands)
There have been no material changes in our assessment of risk factors affecting our business since
those presented in Item 1A of our Annual Report on Form 10-K for the year ended September 30, 2009.
Our updated risk factors are included below in this Item 1A.
Our business, financial condition and operating results can be affected by a number of factors,
including those described below, any one of which could cause our actual results to vary materially
from recent results or from our anticipated future results. Any of these risks could also
materially and adversely affect our business, financial condition or the price of our common stock
or other securities.
We depend on a limited number of customers for most of our sales in our Specialty Chemicals,
Aerospace Equipment and Fine Chemicals segments and the loss of one or more of these customers
could have a material adverse effect on our financial position, results of operations and cash
flows.
Most of the perchlorate chemicals we produce, which accounted for 88% of our total revenues in the
Specialty Chemicals segment for the fiscal year ended September 30, 2009 (Fiscal 2009) and
approximately 28% of our total revenues for Fiscal 2009, are purchased by a small number of
customers. For example, Alliant Techsystems Inc., one of our ammonium perchlorate, or AP,
customers, accounted for 15% of our total revenues for Fiscal 2009. Should our relationship with
one or more of our major Specialty Chemicals or Aerospace Equipment customers change adversely, the
resulting loss of business could have a material adverse effect on our financial position, results
of operations and cash flows. In addition, if one or more of our major Specialty Chemicals or
Aerospace Equipment customers substantially reduced their volume of purchases from us or otherwise
delayed some or all of their purchase from us, it could have a material adverse effect on our
financial position, results of operations and cash flows. Should one of our major Specialty
Chemicals or Aerospace Equipment customers encounter financial difficulties, the exposure on
uncollectible receivables and unusable inventory could have a material adverse effect on our
financial position, results of operations and cash flows.
Furthermore, our Fine Chemicals segments success is largely dependent upon the manufacturing by
Ampac Fine Chemicals LLC (AFC) of a limited number of registered intermediates and active
pharmaceutical ingredients for a limited number of key customers. One customer of AFC accounted for
24% of our consolidated revenue and the top four customers of AFC accounted for approximately 93%
of its revenues, and 46% of our consolidated revenues, in Fiscal 2009. Negative development in
these customer relationships or in the customers business, or failure to renew or extend certain
contracts, may have a material adverse effect on the results of operations of AFC. Moreover, one or
more of these customers might reduce their orders in the future, or one or more of them may attempt
to renegotiate prices, which could have a similar negative effect on the results of operations of
AFC. For example, in Fiscal 2009, Fine Chemicals segment revenues declined as compared to the
fiscal year ended September 30, 2008 (Fiscal 2008), in part due to a decline in revenues from
central nervous system products related to a customer deferring a portion of an order for a central
nervous system product in Fiscal 2009. In addition, if the pharmaceutical products that AFCs
customers produce using its compounds experience any problems, including problems related to their
safety or efficacy, delays in
- 40 -
Table of Contents
filing with or approval by the U.S. Food and Drug Administration, or FDA, failures in achieving
success in the market, expiration or loss of patent/regulatory protection, or competition,
including competition from generic drugs, these customers may substantially reduce or cease to
purchase AFCs compounds, which could have a material adverse effect on the revenues and results of
operations of AFC.
The inherent limitations of our fixed-price or similar contracts may impact our profitability.
A substantial portion of our revenues are derived from our fixed-price or similar contracts. When
we enter into fixed-price contracts, we agree to perform the scope of work specified in the
contract for a predetermined price. Many of our fixed-price or similar contracts require us to
provide a customized product over a long period at a pre-established price or prices for such
product. For example, when AFC is initially engaged to manufacture a product, we often agree to set
the price for such product, and any time-based increases to such price, at the beginning of the
contracting period and prior to fully testing and beginning the customized manufacturing process.
Depending on the fixed price negotiated, these contracts may provide us with an opportunity to
achieve higher profits based on the relationship between our total estimated contract costs and the
contracts fixed price. However, we bear the risk that increased or unexpected costs may reduce our
profit or cause us to incur a loss on the contract, which could reduce our net sales and net
earnings. Ultimately, fixed-price contracts and similar types of contracts present the inherent
risk of un-reimbursed cost overruns, which could have a material adverse effect on our operating
results, financial condition, or cash flows. Moreover, to the extent that we do not anticipate the
increase in cost over time to produce the products which are the subject of our fixed-price
contracts, our profitability could be adversely affected.
The numerous and often complex laws and regulations and regulatory oversight to which our
operations and properties are subject, the cost of compliance, and the effect of any failure to
comply could reduce our profitability and liquidity.
The nature of our operations subject us to extensive and often complex and frequently changing
federal, state, local and foreign laws and regulations and regulatory oversight, including with
respect to emissions to air, discharges to water and waste management as well as with respect to
the sale and, in certain cases, export of controlled products. For example, in our Fine Chemicals
segment, modifications, enhancements or changes in manufacturing sites of approved products are
subject to complex regulations of the FDA, and, in many circumstances, such actions may require the
express approval of the FDA, which in turn may require a lengthy application process and,
ultimately, may not be obtainable. The facilities of AFC are periodically subject to scheduled and
unscheduled inspection by the FDA and other governmental agencies. Operations at these facilities
could be interrupted or halted if such inspections are unsatisfactory and we could experience fines
and/or other regulatory actions if we are found not to be in regulatory compliance. AFCs
customers face similarly high regulatory requirements. Before marketing most drug products, AFCs
customers generally are required to obtain approval from the FDA based upon pre-clinical testing,
clinical trials showing safety and efficacy, chemistry and manufacturing control data, and other
data and information. The generation of these required data is regulated by the FDA and can be
time-consuming and expensive, and the results might not justify approval. Even if AFCs customers
are successful in obtaining all required pre-marketing approvals, post-marketing requirements and
any failure on either AFCs or its customers part to comply with other regulations could result in
suspension or limitation of approvals or commercial activities pertaining to affected products.
Because we operate in highly regulated industries, we may be affected significantly by legislative
and other regulatory actions and developments concerning or impacting various aspects of our
operations and products or our customers. To meet changing licensing and regulatory standards, we
may be required to make additional significant site or operational modifications, potentially
involving substantial expenditures or the reduction or suspension of certain operations. For
example, in our Fine Chemicals segment, any regulatory changes could impose on AFC or its customers
changes to manufacturing methods or facilities, pharmaceutical importation, expanded or different
labeling, new approvals, the recall, replacement or discontinuance of certain products, additional
record keeping, testing, price or purchase controls or limitations, and expanded documentation of
the properties of certain products and scientific
- 41 -
Table of Contents
substantiation. AFCs failure to comply with governmental regulations, in particular those of the
FDA, can result in fines, unanticipated compliance expenditures, recall or seizure of products,
delays in, or total or partial suspension or withdrawal of, approval of production or distribution,
suspension of the FDAs review of relevant product applications, termination of ongoing research,
disqualification of data for submission to regulatory authorities, enforcement actions, injunctions
and criminal prosecution. Under certain circumstances, the FDA also has the authority to revoke
previously granted drug approvals. Although we have instituted internal compliance programs, if
regulations change and compliance is deficient in any significant way, it could have a material
adverse effect on us. In our Specialty Chemicals and Fine Chemicals segments, changes in
environmental regulations could result in requirements to add or modify emissions control, water
treatment, or waste handling equipment, processes or arrangements, which could impose significant
additional costs for equipment at and operation of our facilities.
Moreover, in other areas of our business, we, like other government and military contractors and
subcontractors, are subject directly or indirectly in many cases to government contracting
regulations and the additional costs, burdens and risks associated with meeting these heightened
contracting requirements. Failure to comply with government contracting regulations may result in
contract termination, the potential for substantial civil and criminal penalties, and, under
certain circumstances, our suspension and debarment from future U.S. government contracts for a
period of time. For example, these consequences could be imposed for failing to follow procurement
integrity and bidding rules, employing improper billing practices or otherwise failing to follow
cost accounting standards, receiving or paying kickbacks or filing false claims. In addition, the
U.S. government and its principal prime contractors periodically investigate the U.S. governments
contractors and subcontractors, including with respect to financial viability, as part of the U.S.
governments risk assessment process associated with the award of new contracts. Consequently, for
example, if the U.S. government or one or more prime contractors were to determine that we were not
financially viable, our ability to continue to act as a government contractor or subcontractor
would be impaired. Further, a portion of our business involves the sale of controlled products
overseas, such as supplying AP to various foreign defense programs and commercial space programs.
Foreign sales subject us to numerous additional complex U.S. and foreign laws and regulations,
including laws and regulations governing import-export controls applicable to the sale and export
of munitions and other controlled products and commodities, repatriation of earnings, exchange
controls, the Foreign Corrupt Practices Act, and the anti-boycott provisions of the U.S. Export
Administration Act. The costs of complying with the various and often complex and frequently
changing laws and regulations and regulatory oversight applicable to us and the businesses in which
we engage, and the consequences should we fail to comply, even inadvertently, with such
requirements, could be significant and could reduce our profitability and liquidity.
In addition, we are subject to numerous federal laws and regulations due to our status as a
publicly traded company, as well as rules and regulations of The NASDAQ Stock Market LLC. Any
changes in these legal and regulatory requirements could increase our compliance costs and
negatively affect our results of operations.
A significant portion of our business depends on contracts with the government or its prime
contractors or subcontractors and these contracts are impacted by governmental priorities and are
subject to potential fluctuations in funding or early termination, including for convenience, any
of which could have a material adverse effect on our operating results, financial condition or cash
flows.
Sales to the U.S. government and its prime contractors and subcontractors represent a significant
portion of our business. In Fiscal 2009, our Specialty Chemicals segment generated approximately
26% of consolidated revenues, primarily sales of Grade I AP, and our Aerospace Equipment segment
generated approximately 6% of consolidated revenues, each from sales to the U.S. government, its
prime contractors and subcontractors. One significant use of Grade I AP historically has been in
NASAs Space Shuttle program. Consequently, the long-term demand for Grade I AP may be driven by
the timing of the retirement of the Space Shuttle fleet as well as by the development of
next-generation space exploration vehicles, including the development and testing of a new heavy
launch vehicle used to transport materials and supplies to the International Space Station, and
potentially elsewhere, and the number of space
- 42 -
Table of Contents
exploration launches. Accordingly, demand for AP remains subject to potential changes in space
exploration program direction and budgetary restrictions, which may result in changes in
next-general space exploration vehicles and the timing associated with their development. If the
use of AP as the oxidizing agent for solid propellant rockets or the use of solid propellant
rockets in NASAs space exploration programs are discontinued or significantly reduced, it could
have a material adverse effect on our operating results, financial condition, or cash flows.
The funding of U.S. governmental programs is generally subject to annual congressional
appropriations, and congressional priorities are subject to change. In the case of major programs,
U.S. government contracts are usually incrementally funded. In addition, U.S. government
expenditures for defense and NASA programs may fluctuate from year to year and specific programs,
in connection with which we may receive significant revenue, may be terminated or curtailed. Recent
credit and other economic crises, and the U.S. governments corresponding actions, may result in
cutbacks in major government programs. A decline in government expenditures or any failure by
Congress to appropriate additional funds to any program in which we or our customers participate,
or any contract modification as a result of funding changes, could materially delay or terminate
the program for us or for our customers. Moreover, the U.S. government may terminate its contracts
with its suppliers either for its convenience or in the event of a default by the supplier. Since a
significant portion of our customer base is either the U.S. government or U.S. government
contractors or subcontractors, we may have limited ability to collect fully on our contracts when
the U.S. government terminates its contracts. If a contract is terminated by the U.S. government
for convenience, recovery of costs typically would be limited to amounts already incurred or
committed, and our profit would be limited to work completed prior to termination. Moreover, in
such situations where we are a subcontractor, the U.S. government contractor may cease purchasing
our products if its contracts are terminated. We may have resources applied to specific
government-related contracts and, if any of those contracts were terminated, we may incur
substantial costs redeploying these resources. Given the significance to our business of U.S.
government contracts or contracts based on U.S. government contracts, fluctuations or reductions in
governmental funding for particular governmental programs and/or termination of existing
governmental programs and related contracts may have a material adverse effect on our operating
results, financial condition or cash flow.
We may be subject to potentially material costs and liabilities in connection with environmental or
health matters.
Some of our operations may create risks of adverse environmental and health effects, any of which
might not be covered by insurance. In the past, we have been required to take remedial action to
address particular environmental and health concerns identified by governmental agencies in
connection with the production of perchlorate. It is possible that we may be required to take
further remedial action in the future in connection with our production of perchlorate, whether at
our former facility in Henderson, Nevada, or at our current production facility in Iron County,
Utah, or we may enter voluntary agreements with governmental agencies to take such actions.
Moreover, in connection with other operations, we may become obligated in the future for
environmental liabilities if we fail to abide by limitations placed on us by governmental agencies.
There can be no assurance that material costs or liabilities will not be incurred or restrictions
will not be placed upon us in order to rectify any past or future occurrences related to
environmental or health matters. Such material costs or liabilities, or increases in, or charges
associated with, existing environmental or health-related liabilities, also may have a material
adverse effect on our operating results, earnings or financial condition.
Review of Perchlorate Toxicity by the EPA. Perchlorate is not currently included in the list of
hazardous substances compiled by the U.S. Environmental Protection Agency, or EPA, but it is on the
EPAs Contaminant Candidate List. The National Academy of Sciences, the EPA and certain states have
set or discussed certain guidelines on the acceptable levels of perchlorate in water. The outcome
of the federal EPA action, as well as any similar state regulatory action, will influence the
number, if any, of potential sites that may be subject to remediation action, which could, in turn,
cause us to incur material costs. While the presence of regulatory review presents general business
risk to the Company, we are currently unaware of any regulatory proposal that would have a material
effect on our results of operations and financial position or that would cause us to significantly
modify or curtail our business practices. It is
- 43 -
Table of Contents
possible that the regulatory agencies may change existing, or establish new, standards for
perchlorate, which could lead to additional expenditures for environmental remediation in the
future, and/or additional, potentially material costs to defend against new claims resulting from
such regulatory agency actions.
Perchlorate Remediation Project in Henderson, Nevada. We commercially manufactured perchlorate
chemicals at a facility in Henderson, Nevada, or the AMPAC Henderson Site, until May 1988. In
1997, the Southern Nevada Water Authority, or SNWA, detected trace amounts of the perchlorate anion
in Lake Mead and the Las Vegas Wash. Lake Mead is a source of drinking water for Southern Nevada
and areas of Southern California. The Las Vegas Wash flows into Lake Mead from the Las Vegas
valley. In response to this discovery by SNWA, and at the request of the Nevada Division of
Environmental Protection, or NDEP, we engaged in an investigation of groundwater near the AMPAC
Henderson Site and down gradient toward the Las Vegas Wash. At the direction of NDEP and the EPA,
we conducted an investigation of remediation technologies for perchlorate in groundwater with the
intention of remediating groundwater near the AMPAC Henderson Site. In the fiscal year ended
September 30, 2005 (Fiscal 2005), we submitted a work plan to NDEP for the construction of a
remediation facility near the AMPAC Henderson Site. The permanent plant began operation in December
2006. Late in Fiscal 2009, we gained additional information from groundwater modeling that
indicates groundwater emanating from the AMPAC Henderson Site in certain areas in deeper zones
(more than 150 feet below ground surface) is moving toward our existing remediation facility at a
much slower pace than previously estimated. As a result of this additional data, we re-evaluated
our existing remediation operations and determined to install additional groundwater extraction
wells in the deeper, more concentrated areas, thereby providing for a more aggressive remediation
treatment. We currently anticipate that the new equipment at such extraction wells will become
operational in approximately fall 2011.
Henderson Site Environmental Remediation Reserve. During Fiscal 2005 and the fiscal year ended
September 30, 2006, we recorded charges totaling $26,000 representing our estimate of the probable
costs of our remediation efforts at the AMPAC Henderson Site, including the costs for capital
equipment, operating and maintenance (O&M), and consultants. The project consisted of two primary
phases: the initial construction of the remediation equipment phase and the O&M phase. We commenced
the construction phase in late Fiscal 2005, completed an interim system in June 2006, and completed
the permanent facility in December 2006. In the fiscal year ended September 30, 2007, we began the
O&M phase. However, following the receipt, in late Fiscal 2009, of new data regarding groundwater
movement, and following our determination to install additional groundwater extraction wells, we
increased our accruals by approximately $9,600 for the engineering, design, installation and cost
of additional remediation equipment, and we separately increased our accruals by $4,100 for our
estimate of total remaining O&M costs, due primarily to incremental O&M costs to operate and
maintain the additional equipment once installed. The amount of $13,700, representing the sum of
the estimated costs for the additional equipment and the anticipated incremental O&M costs, was
recorded as a charge to earnings in our Fiscal 2009 fourth quarter. For future periods, total O&M
expenses are currently estimated at approximately $1,000 per year and estimated to increase to
approximately $1,300 per year after the additional above-ground remediation equipment becomes
operational. With the additional extraction wells and equipment, we estimate that the total
remaining project life for the existing and new, more aggressive deep
zone systems could
range from 10 to 29 years, beginning with the fiscal year ending September 30, 2010 (Fiscal
2010). Within that range, we estimate that a range of 13 to 23 years is more likely. We are
unable to predict over the longer term the most probable life. Key factors in determining the
total estimated cost of our remediation efforts include groundwater speed, perchlorate
concentrations, aquifer characteristics and forecasted groundwater extraction rates and annual O&M
costs. As of December 31, 2009, the aggregate range of anticipated environmental remediation costs
was from approximately $22,300 to approximately $46,500 based on a possible total remaining life of
the project ranging from 10 to 29 years, beginning with Fiscal 2010. The accrued amount was
$26,008, based on the low end of the more likely range of 13 to 23 years, or 13 years, as no amount
within the range was more likely. Our estimates are based on information currently available to us
and may be subject to material adjustment upward or downward in future periods as new facts or
circumstances may indicate.
- 44 -
Table of Contents
Other Environmental Matters. As part of our acquisition of the fine chemicals business of GenCorp
Inc., AFC leased approximately 240 acres of land on a Superfund site in Rancho Cordova, California,
owned by Aerojet-General Corporation, a wholly-owned subsidiary of GenCorp Inc. The Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, or CERCLA, has very strict joint
and several liability provisions that make any owner or operator of a Superfund site a
potentially responsible party for remediation activities. AFC could be considered an operator
for purposes of CERCLA and, in theory, could be a potentially responsible party for purposes of
contribution to the site remediation, although we received a letter from the EPA in November 2005
indicating that the EPA does not intend to pursue any clean up or enforcement actions under CERCLA
against future lessees of the Aerojet property for existing contamination, provided that the
lessees do not contribute to or do not exacerbate existing contamination on or under the Superfund
site. Additionally, pursuant to the EPA consent order governing remediation for this site, AFC will
have to abide by certain limitations regarding construction and development of the site which may
restrict AFCs operational flexibility and require additional substantial capital expenditures that
could negatively affect the results of operations for AFC.
Although we have established an environmental reserve for remediation activities in Henderson,
Nevada, given the many uncertainties involved in assessing environmental liabilities, our
environmental-related risks may from time to time exceed any related reserves.
As of December 31, 2009, we had established reserves in connection with the AMPAC Henderson Site of
approximately $26,008, which we believe to be sufficient to cover our estimated environmental
liabilities for that site as of such time. However, as of such date, we had not established any
other environmental-related reserves. Given the many uncertainties involved in assessing
environmental liabilities, our environmental-related risks may, from time to time, exceed any
related reserves, as we may not have established reserves with respect to such environmental
liabilities, or any reserves we have established may prove to be insufficient. We continually
evaluate the adequacy of our reserves on a quarterly basis, and they could change. For example, as
of the end of Fiscal 2009, we increased our environmental reserves in connection with the AMPAC
Henderson Site by approximately $13,700 as a result of an increase in anticipated costs associated
with remediation efforts at the site. In addition, reserves with respect to environmental matters
are based only on known sites and the known contamination at those sites. It is possible that
additional remediation sites will be identified in the future or that unknown contamination, or
further contamination beyond that which is currently known, at previously identified sites will be
discovered. The discovery of additional environmental exposures at sites that we currently own or
operate or at which we formerly operated, or at sites to which we have sent hazardous substances or
wastes for treatment, recycling or disposal, could lead us to have additional expenditures for
environmental remediation in the future and, given the many uncertainties involved in assessing
environmental liabilities, we may not have adequately reserved for such liabilities or any reserves
we have established may prove to be insufficient.
For each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments, most
production is conducted in a single facility and any significant disruption or delay at a
particular facility could have a material adverse effect on our business, financial position and
results of operations.
Most of our Specialty Chemicals segment products are produced at our Iron County, Utah facility.
Most of our Fine Chemicals segment products are produced at our Rancho Cordova, California facility
and most of our Aerospace Equipment segment products are produced at our Niagara Falls, New York
facility. Our Aerospace Equipment segment also has small manufacturing facilities in Ireland and
the U.K. Any of these facilities could be disrupted or damaged by fire, floods, earthquakes, power
loss, systems failures or similar events. Although we have contingency plans in effect for natural
disasters or other catastrophic events, these events could still disrupt our operations. Even
though we carry business interruption insurance policies, we may suffer losses as a result of
business interruptions that exceed the coverage available under our insurance policies. A
significant disruption at one of our facilities, even on a short-term basis, could impair our
ability to produce and ship the particular business segments products to market on a timely basis,
which could have a material adverse effect on our business, financial position and results of
operations.
- 45 -
Table of Contents
The release or explosion of dangerous materials used in our business could disrupt our operations
and cause us to incur additional costs and liabilities.
Our operations involve the handling, production, storage, and disposal of potentially explosive or
hazardous materials and other dangerous chemicals, including materials used in rocket propulsion.
Despite our use of specialized facilities to handle dangerous materials and intensive employee
training programs, the handling and production of hazardous materials could result in incidents
that shut down (on a short-term basis or for longer periods) or otherwise disrupt our manufacturing
operations and could cause production delays. Our manufacturing operations could also be the
subject of an external or internal event, such as a terrorist attack or external or internal
accident, that, despite our security, safety and other precautions, results in a disruption or
delay in our operations. It is possible that a release of hazardous materials or other dangerous
chemicals from one of our facilities or an explosion could result in death or significant injuries
to employees and others. Material property damage to us and third parties could also occur. For
example, on May 4, 1988, our former manufacturing and office facilities in Henderson, Nevada were
destroyed by a series of massive explosions and associated fires. Extensive property damage
occurred both at our facilities and in immediately adjacent areas, the principal damage occurring
within a three-mile radius. Production of AP ceased for a 15-month period. Significant
interruptions were also experienced in our other businesses, which occupied the same or adjacent
sites. There can be no assurance that another incident would not interrupt some or all of the
activities carried on at our current AP manufacturing site. The use of our products in applications
by our customers could also result in liability if an explosion, fire or other similarly disruptive
event were to occur. Any release or explosion could expose us to adverse publicity or liability for
damages or cause production delays, any of which could have a material adverse effect on our
reputation and profitability and could cause us to incur additional costs and liabilities.
Disruptions in the supply of key raw materials and difficulties in the supplier qualification
process, as well as increases in prices of raw materials, could adversely impact our operations.
Key raw materials used in our operations include sodium chlorate, graphite, ammonia, sodium metal,
nitrous oxide, HCFC-123, and hydrochloric acid. We closely monitor sources of supply to assure that
adequate raw materials and other supplies needed in our manufacturing processes are available. In
addition, as a U.S. government contractor or subcontractor, we are frequently limited to procuring
materials and components from sources of supply that can meet rigorous government and/or customer
specifications. In addition, as business conditions, the U.S. defense budget, and congressional
allocations change, suppliers of specialty chemicals and materials sometimes consider dropping low
volume items from their product lines, which may require, as it has in the past, qualification of
new suppliers for raw materials on key programs. The qualification process may impact our
profitability or ability to meet contract deliveries and/or delivery timelines. Moreover, we could
experience inventory shortages if we are required to use an alternative supplier on short notice,
which also could lead to raw materials being purchased on less favorable terms than we have with
our regular suppliers. We are further impacted by the cost of raw materials used in production on
fixed-price contracts. The increased cost of natural gas and electricity also has a significant
impact on the cost of operating our Specialty Chemicals segment facility.
AFC uses substantial amounts of raw materials in its production processes, in particular chemicals,
including specialty and bulk chemicals, which include petroleum-based solvents. Increases in the
prices of raw materials which AFC purchases from third party suppliers could adversely impact
operating results. In certain cases, the customer provides some of the raw materials which are used
by AFC to produce or manufacture the customers products. Failure to receive raw materials in a
timely manner, whether from a third party supplier or a customer, could cause AFC to fail to meet
production schedules and adversely impact revenues and operating results. Certain key raw materials
are obtained from sources from outside the U.S. Factors that can cause delays in the arrival of raw
materials include weather, political unrest in countries from which raw materials are sourced or
through which they are delivered, terrorist attacks or related events in such countries or in the
U.S., and work stoppages by suppliers or shippers. A delay in the arrival of the shipment of raw
materials from a third party supplier could have a significant impact on AFCs ability to meet its
contractual commitments to customers.
- 46 -
Table of Contents
Prolonged disruptions in the supply of any of our key raw materials, difficulty completing
qualification of new sources of supply, implementing use of replacement materials or new sources of
supply, or a continuing increase in the prices of raw materials and energy could have a material
adverse effect on our operating results, financial condition or cash flows.
Each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments may be unable to
comply with customer specifications and manufacturing instructions or may experience delays or
other problems with existing or new products, which could result in increased costs, losses of
sales and potential breach of customer contracts.
Each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments produces products
that are highly customized, require high levels of precision to manufacture and are subject to
exacting customer and other requirements, including strict timing and delivery requirements.
For example, our Fine Chemicals segment produces chemical compounds that are difficult to
manufacture, including highly energetic and highly toxic materials. These chemical compounds are
manufactured to exacting specifications of our customers filings with the FDA and other regulatory
authorities worldwide. The production of these chemicals requires a high degree of precision and
strict adherence to safety and quality standards. Regulatory agencies, such as the FDA and the
European Medicines Agency, or EMEA, have regulatory oversight over the production process for many
of the products that AFC manufactures for its customers. AFC employs sophisticated and rigorous
manufacturing and testing practices to ensure compliance with the FDAs current Good Manufacturing
Practices or cGMP guidelines and the International Conference on Harmonization Q7A. Because the
chemical compounds produced by AFC are so highly customized, they are also subject to customer
acceptance requirements, including strict timing and delivery requirements. If AFC is unable to
adhere to the standards required or fails to meet the customers timing and delivery requirements,
the customer may reject the chemical compounds. In such instances, AFC may also be in breach of its
customers contract.
Like our Fine Chemicals segment, our Specialty Chemicals and Aerospace Equipment segments face
similar production demands and requirements. In each case, a significant failure or inability to
comply with customer specifications and manufacturing requirements or delays or other problems with
existing or new products could result in increased costs, losses of sales and potential breaches of
customer contracts, which could affect our operating results and revenues.
Successful commercialization of pharmaceutical products and product line extensions is very
difficult and subject to many uncertainties. If a customer is not able to successfully
commercialize its products for which AFC produces compounds or if a product is subsequently
recalled, then the operating results of AFC may be negatively impacted.
Successful commercialization of pharmaceutical products and product line extensions requires
accurate anticipation of market and customer acceptance of particular products, customers needs,
the sale of competitive products, and emerging technological trends, among other things.
Additionally, for successful product development, our customers must complete many complex
formulation and analytical testing requirements and timely obtain regulatory approvals from the FDA
and other regulatory agencies. When developed, new or reformulated drugs may not exhibit desired
characteristics or may not be accepted by the marketplace. Complications can also arise during
production scale-up. In addition, a customers product that includes ingredients that are
manufactured by AFC may be subsequently recalled or withdrawn from the market by the customer. The
recall or withdrawal may be for reasons beyond the control of AFC. Moreover, products may encounter
unexpected, irresolvable patent conflicts or may not have enforceable intellectual property rights.
If the customer is not able to successfully commercialize a product for which AFC produces
compounds, or if there is a subsequent recall or withdrawal of a product manufactured by AFC or
that includes ingredients manufactured by AFC for its customers, it could have an adverse impact on
AFCs operating results, including its forecasted or actual revenues.
- 47 -
Table of Contents
A strike or other work stoppage, or the inability to renew collective bargaining agreements on
favorable terms, could have a material adverse effect on the cost structure and operational
capabilities of AFC.
As of September 30, 2009, AFC had approximately 133 employees that were covered by collective
bargaining or similar agreements. We consider our relationships with our unionized employees to be
satisfactory. In June 2007, AFCs collective bargaining and similar agreements were renegotiated
and extended to June 2010. We are currently in negotiations with the union representing these
employees in anticipation of the expiration of these agreements. If we are unable to negotiate
acceptable new agreements with the union representing these employees upon expiration of the
existing contracts, we could experience strikes or work stoppages. Even if AFC is successful in
negotiating new agreements, the new agreements could call for higher wages or benefits paid to
union members, which would increase AFCs operating costs and could adversely affect its
profitability. If the unionized workers were to engage in a strike or other work stoppage, or other
non-unionized operations were to become unionized, AFC could experience a significant disruption of
operations at its facilities or higher ongoing labor costs. A strike or other work stoppage in the
facilities of any of its major customers or suppliers could also have similar effects on AFC.
The pharmaceutical fine chemicals industry is a capital-intensive industry and if AFC does not have
sufficient financial resources to finance the necessary capital expenditures, its business and
results of operations may be harmed.
The pharmaceutical fine chemicals industry is a capital-intensive industry that consumes cash from
our Fine Chemicals segment and our other operations and from borrowings. Increases in capital
expenditures may result in low levels of working capital or require us to finance working capital
deficits, which may be potentially costly or even unavailable in the current conditions of the
credit markets in the U.S. These factors could substantially constrain AFCs growth, increase AFCs
costs and negatively impact its operating results.
We may be subject to potential liability claims for our products or services that could affect our
earnings and financial condition and harm our reputation.
We may face potential liability claims based on our products or services in our several lines of
business under certain circumstances, and any such claims could result in significant expenses,
disrupt sales and affect our reputation and that of our products. For example, a customers product
may include ingredients that are manufactured by AFC. Although such ingredients are generally made
pursuant to specific instructions from our customer and tested using techniques provided by our
customer, the customers product may, nevertheless, be subsequently recalled or withdrawn from the
market by the customer, and the recall or withdrawal may be due in part or wholly to product
failures or inadequacies that may or may not be related to the ingredients we manufactured for the
customer. In such a case, the recall or withdrawal may result in claims being made against us.
Although we seek to reduce our potential liability through measures such as contractual
indemnification provisions with customers, we cannot assure you that such measures will be enforced
or effective. We could be materially and adversely affected if we were required to pay damages or
incur defense costs in connection with a claim that is outside the scope of the indemnification
agreements, if the indemnity, although legally enforceable, is not applicable in accordance with
its terms or if our liability exceeds the amount of the applicable indemnification, or if the
amount of the indemnification exceeds the financial capacity of our customer. In certain instances,
we may have in place product liability insurance coverage, which is generally available in the
market, but which may be limited in scope and amount. In other instances, we may have self-insured
the risk for any such potential claim. There can be no assurance that our insurance coverage, if
available, will be adequate or that insurance coverage will continue to be available on terms
acceptable to us. Given the current economic environment, it is also possible that our insurers may
not be able to pay on any claims we might bring. Unexpected results could cause us to have
financial exposure in these matters in excess of insurance coverage and recorded reserves,
requiring us to provide additional reserves to address these liabilities, impacting profits.
Moreover, any claim brought against us, even if ultimately found to be
- 48 -
Table of Contents
insignificant or without merit, could damage our reputation, which, in turn, may impact our
business prospects and future results.
Technology innovations in the markets that we serve may create alternatives to our products and
result in reduced sales.
Technology innovations to which our current and potential customers might have access could reduce
or eliminate their need for our products, which could negatively impact the sale of those products.
Our customers constantly attempt to reduce their manufacturing costs and improve product quality,
such as by seeking out producers using the latest manufacturing techniques or by producing
component products themselves, if outsourcing is perceived to be not cost effective. To continue to
succeed, we will need to manufacture and deliver products, and develop better and more efficient
means of manufacturing and delivering products, that address evolving customer needs and changes in
the market on a timely and cost-effective basis, using the latest and/or most efficient technology
available. We may be unable to respond on a timely basis to any or all of the changing needs of our
customer base. Separately, our competitors may develop technologies that render our existing
technology and products obsolete or uncompetitive. Our competitors may also implement new
technologies before we are able to do so, allowing them to provide products at more competitive
prices. Technology developed by others in the future could, among other things, require us to
write-down obsolete facilities, equipment and technology or require us to make significant capital
expenditures in order to stay competitive. Our failure to develop, introduce or enhance products
and technologies able to compete with new products and technologies in a timely manner could have
an adverse effect on our business, results of operations and financial condition.
We are subject to strong competition in certain industries in which we participate and therefore
may not be able to compete successfully.
Other than the sale of AP, for which we are the only North American provider, we face competition
in all of the other industries in which we participate. Many of our competitors have financial,
technical, production, marketing, research and development and other resources substantially
greater than ours. As a result, they may be better able to withstand the effects of periodic
economic or business segment downturns. Moreover, barriers to entry, other than capital
availability, are low in some of the product segments of our business. Consequently, we may
encounter intense bidding for contracts. Capacity additions or technological advances by existing
or future competitors may also create greater competition, particularly in pricing. Further, the
pharmaceutical fine chemicals market is fragmented and competitive. Pharmaceutical fine chemicals
manufacturers generally compete based on their breadth of technology base, research and development
and chemical expertise, flexibility and scheduling of manufacturing capabilities, safety record,
regulatory compliance history and price. AFC faces increasing competition from pharmaceutical
contract manufacturers, in particular competitors located in the Peoples Republic of China and
India, where facilities, construction and operating costs are significantly less. If AFC is unable
to compete successfully, its results of operations may be materially adversely impacted.
Furthermore, there is a worldwide over-capacity of the ability to produce sodium azide, which
creates significant price competition for that product. Maintaining and improving our competitive
position will require continued investment in our existing and potential future customer
relationships as well as in our technical, production, and marketing operations. We may be unable
to compete successfully with our competitors and our inability to do so could result in a decrease
in revenues that we historically have generated from the sale of our products.
Due to the nature of our business, our sales levels may fluctuate causing our quarterly operating
results to fluctuate.
Our quarterly and annual sales are affected by a variety of factors that could lead to significant
variability in our operating results. In our Specialty Chemicals segment, the need for our products
is generally based on contractually defined milestones that our customers are bound by and these
milestones may fluctuate from quarter to quarter resulting in corresponding sales fluctuations. In
our Fine Chemicals segment, some of our products require multiple steps of chemistry, the
production of which can span multiple quarterly periods. Revenue is typically recognized after the
final step and when the product has been
- 49 -
Table of Contents
delivered and accepted by the customer. As a result of this multi-quarter process, revenues and
related profits can vary from quarter to quarter. Consequently, due to factors inherent in the
process by which we sell our products, changes in our operating results may fluctuate from quarter
to quarter and could result in volatility in our common stock price.
The inherent volatility of the chemical industry affects our capacity utilization and causes
fluctuations in our results of operations.
Our Specialty Chemicals and Fine Chemicals segments are subject to volatility that characterizes
the chemical industry generally. Thus, the operating rates at our facilities will impact the
comparison of period-to-period results. Different facilities may have differing operating rates
from period to period depending on many factors, such as transportation costs and supply and demand
for the product produced at the facility during that period. As a result, individual facilities may
be operated below or above rated capacities in any period. We may idle a facility for an extended
period of time because an oversupply of a certain product or a lack of demand for that product
makes production uneconomical. The expenses of the shutdown and restart of facilities may adversely
affect quarterly results when these events occur. In addition, a temporary shutdown may become
permanent, resulting in a write-down or write-off of the related assets. Moreover, workforce
reductions in connection with any short-term or long-term shutdowns, or related cost-cutting
measures, could result in an erosion of morale, affect the focus and productivity of our remaining
employees, including those directly responsible for revenue generation, and impair our ability to
retain and recruit talent, all of which in turn may adversely affect our future results of
operations.
A loss of key personnel or highly skilled employees, or the inability to attract and retain such
personnel, could disrupt our operations or impede our growth.
Our executive officers are critical to the management and direction of our businesses. Our future
success depends, in large part, on our ability to retain these officers and other capable
management personnel. From time to time we have entered into employment or similar agreements with
some of our executive officers and we may do so in the future, as competitive needs require. These
agreements typically allow the officer to terminate employment with certain levels of severance
under particular circumstances, such as a change of control affecting our company. In addition,
these agreements generally provide an officer with severance benefits if we terminate the officer
without cause. Although we believe that we will be able to attract and retain talented personnel
and replace key personnel should the need arise, our inability to do so or to do so in a timely
fashion could disrupt the operations of the segment affected or our overall operations.
Furthermore, our business is very technical and the technological and creative skills of our
personnel are essential to establishing and maintaining our competitive advantage. For example,
customers often turn to AFC because very few companies have the specialized experience and
capabilities and associated personnel required for energetic chemistries and projects that require
high containment. Our future growth and profitability in part depends upon the knowledge and
efforts of our highly skilled employees, in particular their ability to keep pace with
technological changes in the fine chemicals, specialty chemicals and aerospace equipment
industries, as applicable. We compete vigorously with various other firms to recruit these highly
skilled employees. Our operations could be disrupted by a shortage of available skilled employees
or if we are unable to attract and retain these highly skilled and experienced employees.
We may continue to expand our operations in part through acquisitions, which could divert
managements attention and expose us to unanticipated liabilities and costs. We may experience
difficulties integrating the acquired operations, and we may incur costs relating to acquisitions
that are never consummated.
Our business strategy includes growth through future possible acquisitions, in particular in
connection with our Fine Chemicals segment. Our future growth is likely to depend, in significant
part, on our ability to successfully implement this acquisition strategy. However, our ability to
consummate and integrate effectively any future acquisitions on terms that are favorable to us may
be limited by the number of attractive and suitable acquisition targets, internal demands on our
resources and our ability to obtain or
- 50 -
Table of Contents
otherwise facilitate cost-effective financing, especially during difficult and unsettled economic
times in the credit market. Our success in integrating newly acquired businesses will depend upon
our ability to retain key personnel, avoid diversion of managements attention from operational
matters, integrate general and administrative services and key information processing systems and,
where necessary, requalify our customer programs. In addition, future acquisitions could result in
the incurrence of additional debt, costs and contingent liabilities. We may also incur costs and
divert managements attention to acquisitions that are never consummated. Integration of acquired
operations may take longer, or be more costly or disruptive to our business, than originally
anticipated. It is also possible that expected synergies from past or future acquisitions may not
materialize.
Although we undertake a diligence investigation of each business that we acquire, there may be
liabilities of the acquired companies that we fail to or are unable to discover during the
diligence investigation and for which we, as a successor owner, may be responsible. In connection
with acquisitions, we generally seek to minimize the impact of these types of potential liabilities
through indemnities and warranties from the seller, which may in some instances be supported by
deferring payment of a portion of the purchase price. However, these indemnities and warranties, if
obtained, may not fully cover the ultimate actual liabilities due to limitations in scope, amount
or duration, financial limitations of the indemnitor or warrantor or other reasons.
We have a substantial amount of debt, and the cost of servicing that debt could adversely affect
our ability to take actions, our liquidity or our financial condition.
As of December 31, 2009, we had outstanding debt totaling $110,252, for which we are required to
make interest payments. Subject to the limits contained in some of the agreements governing our
outstanding debt, we may incur additional debt in the future or we may refinance some or all of
this debt. Our level of debt places significant demands on our cash resources, which could:
| make it more difficult for us to satisfy any other outstanding debt obligations; | |
| require us to dedicate a substantial portion of our cash flow from operations to payments on our debt, reducing the amount of our cash flow available for working capital, capital expenditures, acquisitions, developing our real estate assets and other general corporate purposes; | |
| limit our flexibility in planning for, or reacting to, changes in the industries in which we compete; | |
| place us at a competitive disadvantage compared to our competitors, some of which have lower debt service obligations and greater financial resources than we do; | |
| limit our ability to borrow additional funds; or | |
| increase our vulnerability to general adverse economic and industry conditions. |
If we are unable to generate sufficient cash flow to service our debt and fund our operating costs,
our liquidity may be adversely affected.
We are obligated to comply with financial and other covenants in our debt that could restrict our
operating activities, and the failure to comply could result in defaults that accelerate the
payment under our debt. Our outstanding debt generally contains various restrictive covenants.
These covenants include provisions restricting our ability to, among other things:
| incur additional debt; | |
| pay dividends or make other restricted payments; | |
| create liens on assets to secure debt; | |
| incur dividend or other payment restrictions with regard to restricted subsidiaries; | |
| transfer or sell assets; | |
| enter into transactions with affiliates; | |
| enter into sale and leaseback transactions; | |
| create an unrestricted subsidiary; | |
| enter into certain business activities; or | |
| effect a consolidation, merger or sale of all or substantially all of our assets. |
- 51 -
Table of Contents
Any of the covenants described above may restrict our operations and our ability to pursue
potentially advantageous business opportunities. Our failure to comply with these covenants could
also result in an event of default that, if not cured or waived, could result in the acceleration
of all or a substantial portion of our debt.
Significant changes in discount rates, rates of return on pension assets, mortality tables and
other factors could affect our estimates of pension obligations, which in turn could affect future
funding requirements and related costs and impact our future earnings.
As of December 31, 2009, we had unfunded pension obligations of $29,055. Pension obligations,
periodic pension expense, and funding requirements are determined using actuarial valuations that
involve several assumptions. The most critical assumptions are the discount rate and the long-term
expected return on assets. Other assumptions include salary increases and retirement age, mortality
and turnover. Some of these assumptions, such as the discount rate and return on pension assets,
are largely outside of our control. Changes in these assumptions could affect our estimates of
pension obligations, which in turn could affect future funding requirements and related costs and
impact our future earnings.
Our shareholder rights plan, Restated Certificate of Incorporation, as amended, and Amended and
Restated By-laws discourage unsolicited takeover proposals and could prevent stockholders from
realizing a premium on their common stock.
We have a shareholder rights plan that may have the effect of discouraging unsolicited takeover
proposals. The rights issued under the shareholder rights plan would cause substantial dilution to
a person or group which attempts to acquire us on terms not approved in advance by our board of
directors. In addition, our Restated Certificate of Incorporation, as amended, and Amended and
Restated By-laws contain provisions that may discourage unsolicited takeover proposals that
stockholders may consider to be in their best interests. These provisions include:
| a classified board of directors; | |
| the ability of our board of directors to designate the terms of and issue new series of preferred stock; | |
| advance notice requirements for nominations for election to our board of directors; and | |
| special voting requirements for the amendment, in certain cases, of our Restated Certificate of Incorporation, as amended, and our Amended and Restated By-laws. |
We are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a
change of control. Together, our charter provisions, Delaware law and the shareholder rights plan
may discourage transactions that otherwise could involve payment of a premium over prevailing
market prices for our common stock.
Our proprietary and intellectual property rights may be violated, compromised, circumvented or
invalidated, which could damage our operations.
We have numerous patents, patent applications, exclusive and non-exclusive licenses to patents, and
unpatented trade secret technologies in the U.S. and certain foreign countries. There can be no
assurance that the steps taken by us to protect our proprietary and intellectual property rights
will be adequate to deter misappropriation of these rights. In addition, independent third parties
may develop competitive or superior technologies that could circumvent the future need to use our
intellectual property, thereby reducing its value. They may also attempt to invalidate patent
rights that we own directly or that we are entitled to exploit through a license. If we are unable
to adequately protect and utilize our intellectual property or proprietary rights, our results of
operations may be adversely affected.
Our common stock price may fluctuate substantially, and a stockholders investment could decline in
value.
The market price of our common stock has been highly volatile during the past several years. For
example, during the 12 months ended September 30, 2009, the highest closing price for our common
- 52 -
Table of Contents
stock was $13.11 and the lowest closing price for our common stock was $3.91. The realization of
any of the risks described in these Risk Factors or other unforeseen risks could have a dramatic
and adverse effect on the market price of our common stock. Moreover, the market price of our
common stock may fluctuate substantially due to many factors, including:
| actual or anticipated fluctuations in our results of operations; | |
| events or concerns related to our products or operations or those of our competitors, including public health, environmental and safety concerns related to products and operations; | |
| material public announcements by us or our competitors; | |
| changes in government regulations or policies, such as new legislation, laws or regulatory decisions that are adverse to us and/or our products; | |
| changes in key members of management; | |
| developments in our industries; | |
| changes in investors acceptable levels of risk; | |
| trading volume of our common stock; and | |
| general economic conditions. |
In addition, the stock market in general has experienced extreme price and volume fluctuations that
have often been unrelated or disproportionate to companies operating performance. In addition, the
global economic environment and potential uncertainty have created significant additional
volatility in the United States capital markets. Broad market and industry factors may materially
harm the market price of our common stock, regardless of our operating performance. In the past,
following periods of volatility in the market price of a companys securities, stockholder
derivative lawsuits and/or securities class action litigation has often been instituted against
that company. Such litigation, if instituted against us, and whether with or without merit, could
result in substantial costs and divert managements attention and resources, which could harm our
business and financial condition, as well as the market price of our common stock. Additionally,
volatility or a lack of positive performance in our stock price may adversely affect our ability to
retain key employees or to use our stock to acquire other companies at a time when use of cash or
financing for such acquisitions may not be available or in the best interests of our stockholders.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES None.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None.
ITEM 5. OTHER INFORMATION None.
ITEM 6. EXHIBITS See attached exhibit index.
- 53 -
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: February 12, 2010 |
AMERICAN PACIFIC CORPORATION |
|||
/s/ Joseph Carleone | ||||
Joseph Carleone President and Chief Executive Officer (Principal Executive Officer) |
||||
/s/ Dana M. Kelley | ||||
Dana M. Kelley Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) |
||||
- 54 -
Table of Contents
EXHIBIT INDEX
EXHIBIT NO. | DOCUMENT DESCRIPTION | |
3.1
|
Restated Certificate of Incorporation, as amended, of American Pacific Corporation (incorporated by reference to Exhibit 4.(a) to the registrants Registration Statement on Form S-3 (File No. 33-15674)) | |
3.2
|
Articles of Amendment to the Restated Certificate of Incorporation of American Pacific Corporation, as filed with the Secretary of State, State of Delaware, on October 7, 1991 (incorporated by reference to Exhibit 4.3 to the registrants Registration Statement on Form S-3 (File No. 33-52196)) | |
3.3
|
Articles of Amendment to the Restated Certificate of Incorporation of American Pacific Corporation, as filed with the Secretary of State, State of Delaware, on April 21, 1992 (incorporated by reference to Exhibit 4.4 to the registrants Registration Statement on Form S-3 (File No. 33-52196)) | |
3.4
|
American Pacific Corporation Amended and Restated By-laws (incorporated by reference to Exhibit 3.1 to the registrants Current Report on Form 8-K (File No. 001-08137) filed by the registrant with the Securities and Exchange Commission on September 15, 2008) | |
3.5
|
Rights Agreement, dated as of August 3, 1999, between American Pacific Corporation and American Stock Transfer & Trust Company (incorporated by reference to Exhibit 1 to the registrants Registration Statement on Form 8-A (File No. 001-08137) filed by the registrant with the Securities and Exchange Commission on August 6, 1999) | |
3.6
|
Form of Letter to Stockholders that accompanied copies of the Summary of Rights to Purchase Preferred Shares (incorporated by reference to Exhibit 2 to the registrants Registration Statement on Form 8-A (File No. 001-08137) filed by the registrant with the Securities and Exchange Commission on August 6, 1999) | |
3.7
|
Amendment, dated as of July 11, 2008, between American Pacific Corporation and American Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.1 to the registrants Current Report on Form 8-K (File No. 001-08137) filed by the registrant with the Securities and Exchange Commission on July 11, 2008) | |
31.1
|
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2
|
Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1*
|
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2*
|
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
* | Exhibits 32.1 and 32.2 are furnished to accompany this Quarterly Report on Form 10-Q but shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. |
- 55 -